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ABSTRACT: The solventogenic Clostridia are of interest to the chemical industry 23 
because of their natural ability to produce chemicals such as butanol, acetone and 24 
ethanol from diverse feedstocks. Their use as whole cell factories presents multiple 25 
metabolic engineering targets that could lead to improved sustainability and 26 
profitability of Clostridium industrial processes. However, engineering efforts have been 27 
held back by the scarcity of genetic and synthetic biology tools. Over the last decade, 28 
genetic tools to enable transformation and chromosomal modifications have been 29 
developed, but the lack of a broad palette of synthetic biology parts remains one of the 30 
last obstacles to the rapid engineered improvement of these species for bioproduction. 31 
We have systematically reviewed existing parts that have been used in the modification 32 
of solventogenic Clostridia, revealing a narrow range of empirically chosen and non-33 
engineered parts that are in current use. The analysis uncovers elements, such as 34 
promoters, transcriptional terminators and ribosome binding sites where increased 35 
fundamental knowledge is needed for their reliable use in different applications. 36 
Together, the review provides the most comprehensive list of parts used and also 37 
presents areas where an improved toolbox is needed for full exploitation of these 38 
industrially important bacteria.  39 
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  65 
One of the earliest industrial biotechnology processes used by man was the production 66 
of acetone by bacterial fermentation. The bacterium used was from the genus 67 
Clostridium, which are Gram-positive, spore forming, obligately anaerobic organisms1. In 68 
addition to acetone, these processes produced butanol and ethanol, leading to the 69 
fermentation being given the name ǮABEǯ for Ǯacetone-butanol-ethanolǯ2. ABE-producing 70 
clostridia typically show a biphasic growth pattern, producing acetic and butyric acids 71      ǡ      ǯǯǡ72 
reassimilating the produced acids and producing solvents3. Driven by the demands of 73 
industry, many different ABE-producing clostridial isolates were identified; those 74 
strains that were used in industry are primarily represented by four species4,5, namely 75 
Clostridium acetobutylicum, Clostridium beijerinckii, Clostridium saccharobutylicum, and 76 
Clostridium saccharoperbutylacetonicum, although ABE fermentation has been observed 77 
in other clostridia6Ȃ8. Furthermore, not all butanol-producing clostridia produce the 78 
canonical trio of solvent products; for example, Clostridium pasteurianum produces 79 
butanol and 1,3-propanediol (instead of acetone) from glycerol9. While the ABE process 80 
had until recently fallen out of favour due to competition from the petrochemical 81 
industry, the necessity of identifying alternative fuels has renewed interest in the 82 
production of butanol as a potential biofuel candidate and sustainable commodity 83 
chemical10. 84 
 85 
 86 
Figure 1. Phylogenetic tree of 16S sequences from selected organisms from the genus Clostridium. The tree was built 87 
using Maximum Likelihood method based on the Tamura-Nei model11. The bootstrap consensus tree inferred from 1000 88 
replicates12 is taken to represent the evolutionary history of the taxa analyzed12. Evolutionary analyses were conducted 89 
in MEGA513. Green circles denote butanol-producing species used in industrial biotechnology (IB), red squares mark risk 90 
group 2 species14 (risk group 3 being highest risk). 91 
  92 
A recent comparative genomics study of many industrial saccharolytic strains (those 93 
preferring sugar as a carbon source) revealed that the known solventogens fall within 94 
two sister clades: one exemplified by C. acetobutylicum and one by C. beijerinckii15 95 
(Figure 1). Interestingly, another comparative genomics paper which included more 96 
genus-wide species but fewer industrial solventogens supported the split, with the 97 ǯ   Clostridium butyricum being more closely related to C. beijerinckii 98 
and the pathogen Clostridium tetani clustering closer to C. acetobutylicum16. Altogether, 99 
these findings serve to re-iterate that complex traits within the Clostridia such as 100 
pathogenicity are paraphyletic (also see Fig. 1). On the other hand, solventogenesis (of 101 
ethanol, butanol or acetone) may be very widespread in the genus, but there has not yet 102 
been a definitive comparative study reporting the extent of its conservation to our 103 
knowledge, and species and strains certainly vary in their productivity17. Topics of 104 
engineering interest have included improved characteristics such as solvent 105 
production18,19, sugar utilisation20,21, growth on alternative feedstocks such as 106 
lignocellulose22Ȃ25 and the production of alternative products26Ȃ28. 107 
 108 
A shortage of biological parts for the solventogenic Clostridia 109 
To manipulate the solventogenic Clostridia using rational engineering, the development 110 
of reliable standard genetic parts for use in synthetic biology is essential. The assembly 111 
of these parts into synthetic gene cassettes and larger gene clusters means that they 112 
must work together in a consistent and predictable manner to become a useful tool for 113 
strain engineering. The basic parts of synthetic biology are the minimal sequence 114 
elements with biological function in gene expression (Figure 2), including promoters, 115 
ribosome binding sites, transcriptional terminators and other factors in the mRNA that 116 
affect stability. Also, synthetic biology tools rely on gene reporters to measure levels of 117 
gene expression, and these elements are often combined into plasmids which need their 118 
own origins of replication. Work in Escherichia coli, Saccharomyces cerevisiae and other 119 
model organisms has been transformed in the past decade by the rapid development, 120 
characterization and standardization of parts. However, work in these organisms 121 
benefits from a legacy of biological knowledge that is not necessarily available when 122 
working in non-model organisms, making the engineering of the latter even more 123 
challenging. 124 
 125 
Figure 2. Features of genetic constructs depicted using symbols from the SBOLv29. Examples of promoters, ribosomal 126 
binding sites, reporters, terminators and replicons are described in the main text. 127 
 128 
 129 
It is also important to note that, of the existing body of molecular biology research in this 130 
genus, the majority has been carried out in C. acetobutylicum ATCC 824. Work in this 131 
species has benefited from a relatively early development of a reliable electroporation 132 
protocol30 and from the publication of the whole genome sequence in 2001, making it 133 
the first published clostridial genome31. However, C. acetobutylicum is only one of many 134 
industrially promising solventogenic clostridia. While the engineering of some of these 135 
species has historically been hindered by a lack of transformation protocols, these are 136 
now available for the transformation of the aforementioned five industrial species30,32Ȃ137 
35. In several cases, development of transformation protocols has required the 138 
circumvention of restriction systems which degrade incorrectly methylated DNA. 139 
Indeed, electroporation of C. acetobutylicum only became viable with the expression of 140 
the B. subtilis phage BA3T I methylase in the E. coli cloning host; this methylates the 141 
sequence GCNGC, which would otherwise be cleaved by the C. acetobutylicum Cac824I 142 
type II restriction enzyme30. Likewise, transformation of C. pasteurianum ATCC 6013 143 
(DSM 525) requires the methylation of CGCG sequences, which has been accomplished 144 
by the use of the M.FnuDII33 or M.BepI36 methylases. Other organisms have more 145 
complex restriction systems; in C. saccharobutylicum NCP 262, which has two type I 146 
restriction systems, expression of the methylation and specificity domains of these 147 
systems on a plasmid in E. coli was sufficient to allow transformation by conjugation34. 148 
Some developments have also been made in transforming non-type strains, which may 149 
have restriction patterns which differ from those of the type strains. For example, C. 150 
pasteurianum NRRL B-598 is part of the C. beijerinckii cluster15 but requires the use of a 151 
dam-/dcm- strain of E. coli for successful transformation, suggesting that the type IV 152 
system of this strain is particularly important37; conversely, C. beijerinckii NCIMB 8052 153 
can be transformed with much greater efficiency even with DNA from a dam+/dcm+ 154 
host38. While an analysis of such developments in the entire genus Clostridium would be 155 
beyond the scope of this review, recent publications by Pyne et al.39 and Minton et al.40 156 
provide a comprehensive review of the development of Clostridium strains for genetic 157 
engineering. However, it is certain that the range of genetically tractable Clostridium 158 
species and strains will expand with future research.  159 
 160 
The resurgent interest in solventogenic Clostridium species suggests that synthetic 161 
biology tools are needed and there are clear shortages of particular biological parts with 162 
characterized activity available for the engineering of these organisms. We believe this 163 
warrants a concerted effort to address the weaknesses in the toolbox. Furthermore, with 164 
the establishment of transformation protocols throughout the genus Clostridium, it is 165 
also important to consider the potential of adapting existing parts and tools for use in 166 
other, less well-developed solventogens. Here, we assess the currently available parts 167 
used in synthetic biology projects, starting first with reporters available to measure gene 168 
expression, then the promoters, terminators working at the level of transcription and 169 
then post-transcriptional factors including mRNA stability, ribosome binding sites, 170 
riboswitches and codon usage. Finally we review the replicons currently being used to 171 
assemble synthetic gene clusters and briefly provide an overview of methods to 172 
introduce these genetic elements onto the chromosome, which has been reviewed 173 
elsewhere40. Overall, we aim to summarize and systematize the existing biological parts 174 
used in the industrial solventogenic Clostridium species in order to highlight areas 175 
where more research is required and accelerate progress in creating a full range of 176 
synthetic biology tools for manipulating these industrially important organisms.  177 
 178 
Reporters of gene expression  179 
 180 
Genetically-encoded reporter systems are the major in vivo gene expression 181 
measurement techniques available and are required to measure the activity of different 182 
parts being tested. The oxygen sensitivity of obligate anaerobes such as the clostridia 183 
limits the ease of use of many reporter systems, including some popular fluorescence-184 
based and enzymatically-based reporters, and has led to the development of some novel 185 
reporters which are slowly being adopted. 186 
Fluorescent Reporter Proteins 187 
 188 
The use of fluorescent reporter proteins is now widespread in biology. Successful use 189 
requires the correct folding and maturation of the fluorescent protein to enable 190 
detection. The level of signal for the fluorescent protein must be sufficiently high to 191 
enable accurate detection as there is no signal amplification as seen in enzymatic 192 
reporters.  193 
GFP-family fluorescent proteins 194 
 195 
The highly engineered family of Green Fluorescent Proteins (GFPs) now includes 196 
variants with improved brightness and photostability and with a range of different 197 
colours (different excitation and emission maxima)41. The major limitation of the GFP-198 
like proteins for anaerobes is the requirement of molecular oxygen for chromophore 199 
maturation and fluorescence42. This excludes the possibility of real-time gene expression 200 
monitoring; however, in vivo observations are still possible in some oxygen-tolerant 201 
clostridia such as Clostridium perfringens43, where yellow fluorescent protein (YFP) was 202 
synthesized and fluorescence was developed after exposure of live cells to atmospheric 203 
oxygen44. 204 
 205 
Using a similar principle, it is possible to obtain a snapshot of the protein levels in whole 206 
cells by exposing fixed anaerobically grown bacteria to atmospheric O2 in a process 207 
termed ǯ  ǯ, enabled by the discovery that GFP-family 208 
proteins can undergo maturation in fixed cells. Two studies have demonstrated the 209 
technique in C. difficile using paraformaldehyde and glutaraldehyde to fix cells 210 
expressing codon-optimized variants of CFP (cyan)45 and mCherry (red)46. This 211 
approach works as the fixatives cross-link primary amines (especially lysine residues) 212 
which are absent from the GFP-family chromophores. Fixed cells offer an advantage to 213 
the imaging of dying live cells as they more accurately represent normal protein 214 
localization (gene expression changes are also likely to occur in dying or metabolically 215 
stressed cells)46. So far, the technique has not been used to systematically quantify gene 216 
expression but rather to label proteins and track their intracellular localization46,47.  217 
Flavin-binding Fluorescent proteins 218 
 219 
The flavin-binding fluorescent proteins (FbFPs) are a class of alternative fluorescent 220 
reporters capable of maturation in anaerobic conditions. The FbFPs are small proteins 221 
(~11-15kDa) that have oxygen-independent fluorescent properties, using a flavin-222 
mononucleotide (FMN) cofactor as the chromophore.  223 
A pioneering study in 2007 reported the development of three anaerobic fluorescent 224 
reporters derived from the LOV (Light-, Oxygen- or Voltage-sensing) domains of 225 
bacterial proteins: BsFbFP derived from YtvA of Bacillus subtilis, PpFbFP from SB2 of 226 
Pseudomonas putida plus an E. coli codon optimized variant of BsFbFP called EcFbFP42. 227 
This domain was engineered to emit fluorescence by mutagenesis of a reactive cysteine 228 
in the FMN-binding pocket42. 229 
These proteins are now commercially available from Evocatal Gmbh under the 230 
trademark name Ǯevoglowǯ. Currently listed variants marketed for use in Clostridium 231 
species include Bs1 (monomeric BsFbFP), Bs2 (dimeric BsFbFP) and Pp1 (PpFbFP). 232 ǯ functionality in C. acetobutylicum was demonstrated by Schulz in 2013; 233 
the highest fluorescence levels were observed for a C. acetobutylicum codon-optimized 234 
Pp1 (     ǲ ?ǳ), followed by codon-optimized Bs2 (referred to as 235 ǲBs3ǳ). Interestingly the same constructs gave inverse results in E. coli48. While Evocatal 236 
GmbH offers C-Pp1 and C-Bs2 Clostridium codon-optimized reporters with publicly 237 
available nucleotide sequences, it is not clear whether the nucleotide sequences 238 
(reflective of the codon optimization approach) are the same as Pp2 and Bs3. A study in 239 
2014 reported the placement of the evoglow Pp1 reporter downstream of the cipP 240 
promoter to monitor growth of Clostridium cellulolyticum on cellulose49. The 241 
functionality of the evoglow Bs2 variant has also been demonstrated in C. 242 
pasteurianum50 and in Clostridium ljungdahlii51. 243 
Another FbFP example, developed from the Arabidopsis thaliana LOV2 domain of the 244 
blue-light receptor protein Phot2, is the improved LOV (iLOV) FbFP52. The iLOV FbFP 245 
has been further modified for enhanced properties, generating variants such as 246 
photostable iLOV 2.1 (phiLOV 2.1) and others53,54. While phiLOV 2.1 FbFP has improved 247 
photostability, it is still substantially lower than that of GFP. A recent study 248 
demonstrated the utility of a C. difficile codon optimized phiLOV 2.1 in three Clostridium 249 
species (expression was driven from an engineered strong xyl promoter)55. Under the 250 
test conditions, the three species exhibited varying levels of fold-increase of 251 
fluorescence over their background autofluorescence level: 3.2-fold increase in C. 252 
difficile R20291 (not a Clostridium sensu stricto species), 5.6-fold in the pathogenic toxin-253 
producer Clostridium sordellii ATCC 9714 and 4.5-fold in the solventogen C. 254 
acetobutylicum ATCC 82455. While the FbFP reporters will be detectable when 255 
expression is driven from very strong promoters, further improvements in brightness 256 
and photostability will make them more generally useful for multiple applications. 257 
 258 
One of the drawbacks of the FbFPs is that all of the available variants are of the same 259 
colour; additionally, unfolding caused by translocation has been reported to result in 260 
loss of fluorescence due to the loss of the bound flavin cofactor54. These limitations 261 
prevent the use of FbFPs as the sole reporters for multi-output circuits or secretion. 262 
Engineering of FbFPs for different emission spectra has proven to be somewhat 263 
complicated; while a simulation study of a theoretical iLOV mutant predicted a red shift 264 
increase56, experimental results showed that the mutation resulted in an overall 265 
brightness decrease and a blue shift of emission57. Research is underway to develop 266 
more fluorescent derivatives of the LOV domains and to explore the potential for 267 
diversifying their colour spectrum56,57. The other limitation of FbFPs is their relative 268 
dimness, which can decrease the sensitivity of a reporter system; depending on the 269 
measurement instrument used,  ǯ      270 
detection limit. Photostability improvements (as in phiLOV) have resulted in a dimmer 271 
mutant53; for applications where a longer exposure time is crucial, the dimmer, stable 272 
protein is preferable, but for an automated single measurement application such as flow 273 
cytometry, the brighter variant may be more suitable. Overall, all fluorescent protein 274 
reporters provide the ability to quantify cell-to-cell heterogeneity of gene expression 275 
(when used in flow cytometry or microscopy), which can be very useful, and while there 276 
are still some limitations with FbFPs, they have the potential to be a route to reliable in 277 
vivo real-time expression monitoring in Clostridium. 278 
 279 
Enzymatic Reporter Proteins 280 
Enzymatic reporters catalyse a (preferably) unique reaction either in vivo or in vitro and 281 
the specific activity is calculated to estimate protein levels and thus gene expression. 282 
Enzymatic reporters require the addition of substrates and cofactors to the assay 283 
reaction mixture as well as the production of cell lysate. This often means that enzymatic 284 
assays involve more preparation steps than fluorescent proteins but can have adjustable 285 
sensitivity by varying substrate levels. Also, in vitro lysate assays are, by definition, bulk 286 
population measurements. 287 
Chloramphenicol acetyltransferase 288 
 289 
The first reporter which has been extensively used in the Clostridium genus, both in vivo 290 
and, more quantitatively, in vitro, is the chloramphenicol acetyltransferase (CAT) 291 
reporter (encoded by catP). The system was first developed for use in C. perfringens (a 292 
medically relevant non-solventogenic bacterium)58 and has since been used in C. 293 
acetobutylicum59. Chloramphenicol acetyltransferase is an enzyme that catalyzes the 294 
covalent attachment of an acetyl group from acetyl-CoA to chloramphenicol60, and is the 295 
basis of the chloramphenicol resistance marker found in many bacterial vectors. 296 
Transfer of the acetyl group exposes the thiol group of CoA, allowing the progress of the 297 
reaction to be observed by addition of 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB, also 298 
known as ǯ); this compound reacts with the free thiol, releasing 5-thio-2-299 
nitrobenzoate, which can be detected by measurement of absorbance at 412 nm60, 61. 300 
The assay relies on a continuous spectrophotometric rate determination to calculate 301 
specific activity. Potential drawbacks include endogenous activity in chloramphenicol 302 
resistant strains (which may be resolved by disruption of the resistance gene) as well as 303 
high levels of endogenous non-specific coenzyme A transferases62 (knockouts of which 304 
would be more laborious and would likely have growth and phenotypic effects) and the 305 
cost of the substrate acetyl-CoA. 306 
Carbohydrate hydrolases: Ⱦ-glucuronidase, Ⱦ-galactosidase, amylase, endoglucanase 307 
 308 
The  ǯ drawbacks led to the adaptation of a classical E. coli reporter in 309 
Clostridium: the Ⱦ-galactosidase enzyme, encoded by lacZ (the gene was derived from 310 
Thermoanaerobacter thermosulfurigenes)62. To quantify enzyme activity 311 
spectrophotometrically, ortho-nitrophenyl-Ⱦ-galactoside (ONPG) is used in an in vitro 312 
assay and an increase in absorbance at 420 nm due to the release of ortho-nitrophenol is 313 
measured. Similarly, the GUS reporter system, which utilizes Ⱦ-glucuronidase (E. coli 314 
gusA), has been used in C. acetobutylicum in a fluorimetric assay with a cell lysate63. The 315 
fluorimetric assay measures the release of 4-methylumbelliferone (4-MU) after cleavage 316 
of 4-MU-Ⱦ-galactoside or 4-MU-Ⱦ-glucuronide (by a Ⱦ-galactosidase or Ⱦ-glucoronidase, 317 
respectively), 4-MU emits light at 460 nm when excited by 365 nm light64. Ⱦ-318 
galactosidase and Ⱦ-glucuronidase reporter systems benefit from the commercially 319 
available range of fluorometric, spectrophotometric and histochemical substrates and 320 
kits, making them an improvement over the CAT assay, although they are still not 321 
inexpensive.  322 
The endogenous amyP gene (encoding an amylase expressed during solventogenesis) 323 
has been used in C. acetobutylicum65 as a reporter to study the phenomenon of strain 324 
degeneration (loss of solventogenesis) which is often caused by loss of the pSOL1 325 
megaplasmid on which amyP is located. A codon-optimized amylase (AmyEopt) has been 326 
used successfully as a secreted reporter in C. difficile by addition of a zinc 327 
metalloprotease PPEP-1 signal sequence66. It is noteworthy that the strain used in the 328 
above study was not capable of degrading starch under laboratory conditions; use of 329 
amylase as a reporter in amylolytic strains (such as C. acetobutylicum ATCC 824) may 330 
require knockout of endogenous amylases to increase signal to background ratio.  331 
In C. beijerinckii, a secreted endoglucanase (eglA) was cloned from C. saccharobutylicum 332 
NCP 262 and used as a reporter for gene expression67; assays used were agar plate and 333 
cell lysate assays which measured substrate (carboxymethylcellulose, CMC) clearance 334 
on plates and product (p-nitrophenol from cleavage of p-nitrophenyl cellobioside) 335 
accumulation in lysate, respectively. 336 
Lipase and Alkaline phosphatase  337 
The lipase encoded by tliA, from Pseudomonas fluorescens SIK W1, has also been used as 338 
a reporter in C. beijerinckii NCIMB 805268. Lipases are enzymes which hydrolyse the 339 
ester bonds found in long-chain acylglycerols, releasing fatty acids69. Activity can thus be 340 
assessed by an enzymatic assay measuring the cleavage of p-nitrophenyl-esters69 such 341 
as p-nitrophenyl decanoate68. However, this reporter was only useable in C. beijerinckii 342 
as this species has a very low endogenous lipase activity. As such, it may not be suitable 343 
in other species, such as C. acetobutylicum, which has been observed to show inducible 344 
lipase activity70. 345 
A colorimetric alkaline phosphatase assay was developed and used in C. difficile in 2015 346 
based on the phoZ gene product from Enterococcus faecalis71. Activity of this gene can be 347 
determined by a colorimetric assay with p-nitrophenyl phosphate as the substrate. Use 348 
in solventogenic clostridia could be limited by native phosphatase activity. In order to 349 
examine the suitability of C. difficile as a host for this reporter, BLAST analysis was used 350 
to screen for phoZ homologues, and activity towards 5-bromo-4-chloro-3-indolyl 351 
phosphate was tested71. While the four main industrial strains do not have a phoZ 352 
homologue, homologues can be found in other species such as C. pasteurianum 353 
(CLPA_RS02340, with 29% identity to phoZ). 354 
Luciferase 355 
 356 
The luciferase (lucB) reporter was also used in C. acetobutylicum successfully, allowing 357 
luminescence detection72. However, it also requires oxygen, ATP and luciferin. Notably, 358 
the cells used in the luciferase assay were neither lysed nor fixed, but were live cells that 359 
were exposed to atmospheric conditions, washed, and kept on ice. This treatment could 360 
conceivably introduce changes in gene expression levels prior to measurement. This 361 
assay has the lowest background signal level but the requirement for live cell exposure 362 
to oxygen may introduce variability. A codon-optimized luciferase (sLucopt) was also 363 
successfully secreted in C. difficile using the aforementioned zinc metalloprotease signal 364 
peptide66. 365 
 366 
While there are many reporter choices available to clostridial researchers, we would 367 
argue that the multiplicity of reporters used has not helped ease the comparison of data 368 
obtained by different laboratories. Altogether, a single reporter has not been established 369 
as a community standard; given the drawbacks of each particular system, it is difficult to 370 
identify one standout reporter, although our hope would be that improved fluorescence 371 
reporters with increased brightness and photostability would be the most useful and 372 
enable single cell studies in live cells. Currently we would advocate a choice of more 373 
than one reporter, enzymatic and fluorescent, and their systematic and comparative use 374 
within the genus. Such an approach could provide insight into the sources of gene 375 
expression variability between strains and provide a starting point for future 376 
engineering. To achieve this seamlessly, it is advisable to explore translational fusions 377 
between reporters; examples from E. coli include a FRET pair YFP-FbFP fusion73 and 378 
Gemini (lacZȽ-GFP) fusion74. If successfully applied to the Clostridium species, such bi-379 
functional reporters have the potential to become a single standard reporter. 380 
Additionally, Ƚ-peptide complementation strategies using the E. coli lacZ gene in B. 381 
subtilis75 and Mycobacterium smegmatis76 have been reported but a similar approach in 382 
Clostridia has not been attempted. Interestingly, the T. thermosulfurigenes-derived LacZ 383 
protein appears to lack the Ƚ-complementation region77 and is a dimer78 (rather than a 384 
tetramer like E. coli LacZ). 385 
Transcription  386 
Transcription is the first stage of gene expression and the main stage for regulation of 387 
gene expression. Most existing biological parts in Clostridium fall within the 388 
transcription category and are mostly promoters (summarized in Table 1). In contrast, 389 
the termination of transcription has been studied relatively little and we present some 390 
analysis on the potential to study and improve the parts available for reliable 391 
termination. 392 
Transcription initiation 393 
Promoters are DNA elements that are capable of driving transcription by RNA 394 
polymerase (RNAP) of downstream regions. Core promoter architecture in bacteria 395 
includes the -10 region or TATAAT box (Pribnow sequence), the -35 region and a spacer 396 
(with an optimal length of 17bp in E. coli) between the two conserved regions79. This 397 
motif is recognized by the housekeeping sigma factor that provides sequence specificity 398 
to RNAP (called RpoD in E. coli and SigA in B. subtilis, C. acetobutylicum and other 399 
solventogens)80,81. Both the consensus sequence and sigma factors bear very significant 400 
similarities between Firmicutes and Escherichia. 401 
In addition, some E. coli promoters contain AT-rich UP elements (upstream of -35 402 
region) that are responsible for recognition by the carboxy-terminal domain of the 403 Ƚ-subunit82, an additional E. coli promoter feature is the Ǯ- ? ?ǯ83 404 
(upstream of the -10 region and within the spacer). Interestingly, near-consensus 405 
promoters (including ones with UP elements) have been found to be significantly more 406 
common in Firmicutes (including Clostridia) than in other bacteria84, a feature that was 407 
not explicable through higher AT-content alone. In Clostridia additional sequences with 408 
resemblances to UP elements (termed phased A-tracts) have been described85 and a 409 
conserved extended -10 region that differs from its E. coli analogue has also been 410 
proposed86. The majority of promoters used in the genetic engineering of clostridia have 411 
been identified from the transcriptional units of important metabolic genes and most 412 
have been shown to be able to drive strong constitutive expression of a gene of 413 
interest87. The most commonly used constitutive promoter in C. acetobutylicum (Table 414 
1) is that of the native thiolase gene (thlA)88,89, which has been used for the expression of 415 
genes involved in production of solvents such as butanol90 and isopropanol26, the 416 
transcriptional regulator gene tetR91 (used a minimal promoter variant- miniPthl), and, 417 
in a modified form, for the expression of cellulosomal scaffoldins92 and glycoside 418 
hydrolases25,93. The C. acetobutylicum thiolase enzyme catalyzes the condensation of 419 
acetoacetyl-CoA from acetyl-CoA which are central metabolic intermediates88. The C. 420 
acetobutylicum thlA promoter (hereinafter referred to as thlA) is a sigA-dependent 421 
promoter (as evidenced by its near-consensus -35 and -10 regions89); however, in its 422 
normally chromosomal context it is also the subject of regulation by the redox-sensing 423 
transcriptional repressor Rex94. Rex inactivation was found to increase native thlA 424 
activity in C. acetobutylicum about 12-fold95. The Rex-binding site has been omitted from 425 
the core promoter in commonly used synthetic constructs96; yet this binding site is 426 
conserved in the promoters of orthologous genes from other solventogens (according to 427 
the RegPrecise database97 and our promoter region alignments), suggesting that there 428 
are additional levels of control for this promoter that could be easily added by addition 429 
of the Rex sites if desirable. Indeed, some studies using similar promoters such as thlA 430 
and ptb have reported conflicting strength/activity findings, which may well be due to 431 
the cloning of regions of varying length (that likely include regulator binding sites such 432 
as Rex) and choosing to include the native RBSs or not (such as the ones reported 433 
between promoters in the Schulz 201348 and Girbal 200363 studies). 434 
 435 
Thiolase promoters have also been used for expression in other clostridia such as C. 436 
beijerinckii98 and C. pasteurianum99. However, gene expression data (RNAseq from C. 437 
beijerinckii) indicates that there are other genes that have higher expression levels than 438 
the ones currently used as promoter sources; many of those genes encoded are 439 
hypothetical proteins100. Recently, Yang et al., 2017 constructed a sequence logo of 18 440 
promoters previously identified in C. acetobutylicum which revealed a strongly 441 
conserved -10 region. Using degenerate oligos to mutagenize the core thlA promoter 442 
elements, the authors were able to generate a promoter library of variable strengths, 443 
including mutations that increased the strength of the promoter, suggesting that thlA 444 
can be improved further using synthetic biology approaches.  445 
 446 
The use of a constitutive promoter may not always be desirable; it may be preferable to 447 
use an inducible promoter, allowing controlled expression of a gene of interest. So far, 448 
the only naturally inducible promoters exemplified in a solventogenic clostridium are 449 
the Staphylococcus xylosus xylA promoter, which is repressed by XylR in the absence of 450 
D-xylose63, and the C. perfringens bgaL promoter, which is repressed by BglR in the 451 
absence of lactose101. However, constitutive promoters can be made inducible by 452 
addition of operator sites (for transcriptional repressors) or by the addition of binding 453 
sites for activators, and several such promoters have been developed for use in 454 
solventogenic clostridia. LacI-repressible versions of thiolase and ferredoxin promoters 455 
have allowed the construction of clostridial expression constructs for genes where 456 
expression in E. coli would be toxic24,25,93. In C. acetobutylicum, the fac promoter 457 
(Clostridium pasteurianum ferredoxin promoter with lac operator) is able to function as 458 
an IPTG-inducible system in the presence of LacI, allowing approximately 10-fold 459 
induction59. A TetR-repressed, anhydrotetracycline-inducible promoter has also been 460 
used in C. acetobutylicum, generated by the fusion of the chloramphenicol 461 
acetyltransferase promoter pcm with the tetracycline operator tetO91. This promoter 462 
could achieve up to 313-fold induction, although high levels of anhydrotetracycline were 463 
inhibitory to growth. However, operators are known to influence the basal activity of the 464 
promoter102. In fact, a recent study in E. coli found the core RpoD promoter too sensitive 465 
to sequence context and operator insertions to be a suitable target for forward 466 
engineering efforts and turned to extracellular sigma factors (ECFs) with T7 RNAP 467 
whose promoter core sequences they found to be more insensitive to operator 468 
addition103. An alternative strategy - CRISPR-mediated repression of transcription - has 469 
been demonstrated in several solventogenic species, namely C. acetobutylicum104, C. 470 
beijerinckii98 and C. pasteurianum50, 471 
 472 
Orthogonal expression systems, i.e. promoters that require other non-native elements 473 
for activity (commonly an alternative sigma factor or phage polymerase), first found 474 
widespread use in the cloning of genes with toxic products. This approach allows the 475 
total repression of genes until they are introduced into the organism of interest. A 476 
commonly used example in E. coli is the T7 promoter, which requires the phage T7 477 
polymerase for activity105. An example from Clostridia is expression driven from the C. 478 
difficile tcdB promoter that is dependent on the native sigma factor TcdR. The tcdB 479 
promoter is highly active in C. acetobutylicum, but only when tcdR has been integrated 480 
into the genome59. This enabled the high-level expression of a mariner transposon in C. 481 
acetobutylicum without negative effects on the E. coli cloning host. There is a strong case 482 
for designing these orthologonal-type systems as simply using a clostridial 483 
housekeeping promoter (such as the thlA promoter) with a clostridial ribosome binding 484 
site would not provide orthogonality in commonly used cloning hosts such as E. coli or B. 485 
subtilis due to the degree of conservation between the transcription and translation 486 
initiation systems amongst these organisms; on the contrary, as a rule strong clostridial 487 
promoters and RBSs (see translation initiation section) often retain their strength in E. 488 
coli whereas the opposite is observed more rarely, this is likely due to the on average 489 
higher similarity to the Bacteria-wide consensus translation and transcription initiation 490 
signals in Clostridium86,106. Interestingly, AT-rich DNA can be toxic to E. coli (clostridial 491 
genomes are very AT-rich) due to transcriptional activity from spurious intragenic 492 
promoters and RNAP titration107. This is exacerbated by the fact that the E. coli extended 493 
-10 region, which is sufficient alone for transcription initiation in E. coli, could also be 494 
present by chance in Clostridium-derived sequences, increasing the likelihood of 495 
spurious and unpredictable transcription during cloning in E. coli. 496 
Table 1. Promoters used in engineering of C. acetobutylicum 497 
Promoter Comments 
Constitutive  
thlA (C. acetobutylicum) 
 
Widely used for constitutive gene expression in C. acetobutylicum for example expression on C. beijerinckii ald, C. ljungdahlii bdh90, 
C. acetobutylicum adc, ctfA, ctfB,26 & tetR (miniPthl variant)91. Activity analyzed using GusA63 and several FbFP48reporters 
thl (C. perfringens) Used for expression of srtA genes from C. acetobutylicum, L. monocytogenes, and B. cereus25. 
fdx (C. sporogenes) Activity analyzed using CatP reporter59. Used in the ClosTron system for expression of the Ll.LtrB intron108. Used for expression of 
spoA integrated into the chromosome for complementation of a spoA mutant109.  
Controlled  
thl (thl with double lac operator) lac-repressed version of thlA. Used to express a miniscaffoldin cipc192 & weakened version for expression of mannanase man5K93. 
thlOid (thl with single lac operator)  A lac-repressible version, used to drive chromosomal expression of the C. cellulolyticum glycoside hydrolase xyn10A25. 
fac (single lac operator, derived from C. 
pasteurianum) 
Activity analyzed using CatP reporter59,110 and Pp2 FbFP48. Formerly used in the ClosTron system for expression of the Ll.LtrB 
intron110. Used for expression of codA in the C. acetobutylicum knockout vector pMTL-SC7515109. 
fdxOid (fdx with single lac operator) Used for chromosomal expression of C. cellulolyticum glycoside hydrolase cel9G25. Has RBS from C. acetobutylicum thlA promoter. 
facOid (fac with single lac operator) Used for chromosomal expression of C. cellulolyticum glycoside hydrolase cel48F25. Has RBS from C. acetobutylicum thlA promoter. 
tcdB (C. difficile) Developed for an orthogonal expression system, requires the exogenous sigma factor TcdR for function59.  
xylA (S. xylosus) Repressed by XylR and inducible by D-ǢȾ-glucuronidase reporter giving 17-fold induction with D-xylose63. 
pcm (tetO1-containing variants)  Repressed by TetR; inducible in the presence of anhydrotetracycline91. 
bgaL (C. perfringens) 
xyl/tetO (B. subtilis) 
Repressed by BgaR and inducible by lactose101. 
Repressed by TetR111; activity in C. acetobutylicum shown by phiLOV 2.1 Opt FbFP expression55 
Fermentation phase-specific  
adc (C. acetobutylicum) Ⱦ-glucuronidase63ǡȾ-galactosidase72 and Pp2 FbFP48. Primarily active after onset of solventogenesis. 
ptb (C. acetobutylicum) Ⱦ-glucuronidase63, luciferase72 and Pp2 FbFP48. Active during acidogenesis (not solventogenesis)  
ptb (C. beijerinckii) Activity assessed through expression of lacI59. 
sol (C. acetobutylicum) Ⱦ-galactosidase & luciferase reporters72. Weak expression, primarily active during late exponential phase. 
bdhA (C. acetobutylicum) AnalyzȾ-galactosidase reporter72. Comparatively weak expression, primarily active in early exponential phase. 
bdhB (C. acetobutylicum) AnalyzȾ-galactosidase reporter72. Primarily active until onset of solventogenesis. 
hydA (C. acetobutylicum) 
adhe2 (C. acetobutylicum) 
Activity analyzȾ-glucuronidase63 and Pp2 FbFP48. High activity during acidogenesis, decreases to low after phase shift 
Activity analyzed using Pp2 FbFP48. Strong expression during solventogenesis48,112 
Transcription termination 498 
Bacteria have two distinct mechanisms that function in transcription termination. Both 499          ?ǯ    Ǥ -500 
dependent terminators rely on the Rho protein that recognizes a target sequence and 501 
causes RNA polymerase to fall off of the template DNA113. The specific DNA recognition 502 
sites, rut sites, have been used before in genetic circuits114, but not extensively, perhaps 503 
due to the relatively poor mechanistic understanding of the process115. The second 504 
mechanism, which also has been reported to be more widespread116, is referred to as 505 
Rho-independent or intrinsic termination and relies on the folding of a short GC rich 506 
hairpin followed by a poly-U transcribed sequence. The hairpin folding and subsequent 507 
transcription of the U-tract causes the polymerase to pause and leads to transcript and 508 
RNAP dissociation117. This is also facilitated by the fact that ribo-uracil-deoxyribo-509 
adenine is the weakest nucleotide base pair118. Intrinsic terminators are often found 510 
downstream of operons; however, they are also involved in transcription attenuation 511 
when present within coding regions or downstream of promoters119. 512 
 513 
While a number of terminators have been used in the construction of clostridial 514 
expression constructs, often derived from clostridial genes such as adc63,120, fdx109, 515 
CD0164109 and thlA90,121, there have been few published analyses of terminator 516 
strengths in clostridia. The C. pasteurianum fdx terminator has been shown to be highly 517 
effective at preventing read-through inhibition of the replicon from the fac promoter in a 518 
clostridial vector59, and screening of a selection of terminators in C. acetobutylicum25 519 
showed that the E. coli rrnB terminator T1 loop was able to function as an efficient 520 
terminator, reducing expression of a downstream gene. However, these analyses only 521 
took into consideration the effect of the terminator on a downstream target under the 522 
influence of a single promoter. As previously mentioned, the introduction of a 523 
terminator may have an effect on expression of an upstream gene by influencing mRNA 524 
stability, which is not a desirable feature of a standard part122. However, this effect can 525 
be quantified in an appropriately designed assay123. Furthermore, the efficiency of 526 
termination may increase or decrease depending on promoter activity; this has been 527 
recently exploited for the development of a genetic band-pass filter in E. coli124. 528 
Terminator strength has also been shown to be inflǯ529 
a stop codon or when present within a coding region125. A recent study demonstrated 530 
the gradual increase in termination efficiency as distance between the stop codon and 531 
hairpin increased126. The ribosome was found to repress transcriptional termination 532 
when the stop codon and hairpin were in close proximity Ȃ termination repression was 533 
relieved when insulator sequences of approximately 30 bp were used126. Expanding the 534 
range of characterized clostridial terminators is clearly necessary for the development 535 
of a clostridial synthetic biology toolbox. 536 
 537 
One approach that can be undertaken is the use of algorithms to extract putative 538    ǡ    Ǯ ǯǤ veral such 539 
bioinformatics tools exist; they rely on seed sequences, secondary RNA structure 540 
features or both116,127Ȃ129. These bioinformatics tools were developed to aid genome 541      ?ǯ    and may not then detect all the 542 
features required by a functional terminator. In order to evaluate the relative difference 543 
in sequences retrieved by different programs, we compared the output of three searches 544 
performed on the C. acetobutylicum ATCC 824 genome (Figure 3A). The three search 545 
algorithms that were chosen are as follows: TransTermHP (TTHP)128, RNIE116 and 546 
WebGeSTer (WG)130. TTHP is a widely used tool, while ǯ  547 
tool eliminates false positives in comparison to TTHP116. Finally, WebGeSTer was 548 
selected because the authors classify the results into different types of intrinsic 549 
terminators based on overall secondary structure. They discovered that canonical U-550     ȋ Ǯ-ǯȌ form the majority of 551 
structures found within Firmicutes, whereas they are a minority in the E. coli model 552 
where they were first identified129.  553 
554 
Figure 3. Application of terminator prediction software to C. acetobutylicum. A. Outputs from predicted terminator sets derived from the C. acetobutylicum genome by 
application of TransTermHP (TTHP), RNIE and WedGeSTer were compared. B. An alignment of predictions of a putative bi-directional terminator (marked by T sign) 
by all three algorithms (note all three produce separate predictions for plus (+)and minus (-))C. RNA structures predicted by RNAfold215,216 for the TransTermHP 
sequence, drawn with VARNA217; it is worth noting that the base-pairing between the A-tract and U-tract may not form until after termination218. Terminator lengths: 
WG: maximum length (max)-48bp, minimum (min) - 28bp, average (avg) - 35.8bp; RNIE: max-45bp, min- 34bp, avg-41.7bp,TTHP: max-89bp,min-41bp,avg-57.2bp. 
In our analysis, each algorithm was used to produce sets of putative terminator 555 
predictions, which were examined to identify overlapping predictions and are presented 556 
in Fig. 3A. Using the default settings of the different algorithms, the total number of 557 
predictions per program varied considerably, with TTHP and WG each predicting over 558 
1000 terminators while RNIE predicted fewer than 300 (Fig. 3A). Despite this much 559 
smaller set, only about half of the predictions were shared with either TTHP and WG 560 
sets or both, producing a small set of 104 terminators shared by all three methods, an 561 
example of which is illustrated in Fig. 3B, an intergenic region separating two 562 
converging coding sequences, CA_C0323 (a sensory transduction histidine kinase) and 563 
CA_C0324 (a tetratricopeptide-repeats-containing protein). This also illustrates a class 564 
of terminators with particular utility in synthetic biology, namely bi-directional 565 
terminators, which are capable of terminating transcription from both the plus and 566 
minus strands. Our analysis finds that 37 bi-directional terminators are supported by all 567 
three algorithms, supporting the concepts that there are plentiful targets in clostridial 568   Ǯ ǯ       569 
strong terminators. An interesting feature of the bi-directional terminators is their 570 
hypersymmetry131 (can be seen in Fig. 3B). This leads to the possibility to form an 571 
extended hairpin between the so-called A-tract (can act as U-tract in the reverse 572 
transcriptional orientation) and the U-tract (as shown in Fig. 3C). However, as pausing 573 
and termination occur at the U-tract117, the formation of an extended hairpin may not be 574 
relevant and does not appear to contribute to strength in all terminators132. Also, note 575 
that in this example the terminator on the minus strand (also referred to as Crick 576 
strand) is predicted to have a more stable hairpin (rG and rU form a basepair while rA 577 
and rC do not), whereas terminators from both strands are capable of forming an 578 
extended hairpin if fully transcribed as a result of base pairing between the A- and U-579 
tracts. Combined with having a longer U-tract (Fig. 3C), the Crick strand terminator is 580 
possibly the stronger one, interestingly WebGeSTer predicts a smaller terminator 581 
downstream of the one depicted in Fig. 3A (not shown). A previous analysis of the C. 582 
acetobutylicum genome for terminators using TransTerm127, a predecessor of TTHP, 583 
revealed the presence of 66 putative bi-directional terminators133, supporting the 584 
rationale of combining outputs from multiple algorithms to create a small part list for 585 
experimental characterisation. 586 
 587 
Translation  588 
Translation initiation 589 
Bacterial ribosome-binding sites (RBS)        ?ǯ 590 
untranslated region of messenger RNA (mRNA) transcripts, consisting of a Shine-591 
Dalgarno sequence (SD), polynucleotide spacer, and a translation initiation codon134. 592 
Commonly, native promoter-RBS combinations have been used (such as in the 593 
pMTL80000 vectors). An alternative strategy is to use a native RBS (such as that of the C. 594 
acetobutylicum thlA gene) fused to a new promoter, as in a study from 201625 that 595 
generated several new hybrid promoters. Others have experimented with the length of 596 
the spacer135,136. Yet, in contrast to model organisms (E. coli and even B. subtilis), there 597 
are few published comparisons of modified RBSs for use in solventogenic clostridia. 598 
Hence the generation and screening of synthetic RBS libraries could be a promising 599 
route for optimising the expression of synthetic gene constructs in clostridia. 600 
SD sequences provide sequence compleme    ?ǯ terminus of the 16S rRNA 601 
(known as the anti-Shine-Dalgarno or aSD137) which acts as a guide for the ribosome 602 
complex enabling mRNA recognition by the translation machinery and translation 603 
initiation. While most of the knowledge on bacterial translation initiation comes from E. 604 
coli work, early studies indicated that the Firmicute B. subtilis requires a longer 605 
complementary region between the SD and the 16S rRNA to achieve comparable 606 
expression levels138,139. An early study on translation initiation revealed that Firmicutes 607 
have, on average, a higher complementarity of the predicted SD region to the 16S rRNA 608  ?ǯE. coli does106. Recently, a systematic analysis of SD-aSD pairings in B. 609 
subtilis and in E. coli confirmed this trend140. Replicating these studies in solventogens 610 
would provide useful information. 611 
 612 
The spacer is the mRNA region between the SD and the start codon. The aligned spacer 613 
(which  ?ǯ, base-paired to 614 
a SD137,141,142 as revealed by sequence alignment) is of particular importance for 615 
translation initiation137. Defining the length of the aligned spacer precisely is difficult, as 616 
interpretations of the extent of the aSD ȋ ?ǯ ? ?Ȍ 617 
vary. The  ?ǯ  the 16S rRNA gene (aSDs) of B. subtilis is identical to that of C. 618 
perfringens143 (as well as identical to those of solventogenic clostridia, based on our 619 
sequence analysis of published genomes) but to our knowledge there is no reported 620 
experimental validation of the    ? ?   ?ǯ in vivo. Spacers in 621 
different species may have different optimal lengths; for example, spacers of Pyrococcus 622 
abyssi are, on average, roughly 3 nucleotides longer than those of E. coli144, whereas the 623 
spacers in Bifidobacterium longum145 would be considered shorter. According to our 624 
definition of the    ȋ ?ǯ GAUCACCUCCUUUCU  ?ǯȌǡ  C. 625 
acetobutylicum, the native RBS of the thlA promotǯǯ4 bases. 626 
The effect of altering the length of the thlA spacer was recently investigated in two 627 
studies conducted in C. acetobutylicum135,136. Interestingly Yang et al., 2016 showed that 628 
a lengthened thlA RBS spacer with an extra 6 nucleotides (to a total of 14 bases- aligned 629 
spacer of 10bp), encoding a SalI restriction site, did not significantly alter reporter 630 
expression in comparison to the WT thlA RBS. Shortening the spacer below the WT 631 
length resulted in a decrease in expression, while further increases over an aligned 632 
spacer length of 10 bases (by the addition of a XbaI site) removed almost all of the 633 
expression135. 634 
Yang et al. (2016) demonstrated the potential benefits of utilising modified spacers in C. 635 
acetobutylicum135. Overexpression of the biotin synthesis genes bioY, bioD, bioA, and 636 
bioB was observed to provide an improvement in growth phenotype and solvent 637 
production. The thlA promoter was used to drive expression of bioY, bioD and bioA; 638 
replacement of the thlA RBS spacer with a shoǡǯǯ639 
further improvement in growth characteristics. These results demonstrate not only the 640 
ability of modified RBS to optimize expression of synthetic pathways, but also the 641 
necessity of considering the effects of any alterations to the spacer, e.g. the introduction 642 
of restriction sites, when generating synthetic constructs. In 2017, Yang et al. generated 643 
a library of spacers (a BamHI site preceded the start codon in all cases) by starting with 644 
an aligned spacer of 2 bases and progressively increasing its length by 2 bases. After 645 
testing 11 variants the authors found that an aligned spacer of 4 bases gave the 646 
strongest levels of expression followed by 8, 6 and 10 bases in that order. It is 647 
conceivable that not only the length but also the sequence of the spacer might influence 648 
translation initiation, for example the introduction of a secondary SD within the primary 649 ǯǤ 650 
Computational tools to design RBSs exist, such as the RBS calculator, which use 651 
biophysical models of RBS recognition and translation initiation, including RNA base-652 
pairing between the aSD and SD, spacer length and messenger secondary 653 
structure146,147. There are reports that de novo design produces more accurate results 654 
than translation initiation rate prediction of natural sequences for Gram positives148. 655 
 656 
Codon usage during translation 657 
While codon usage is not formallǮbiological partǯǡ it is an important feature of coding 658 
sequences, the differential frequency of synonymous codons amongst genomes, referred 659 
to as codon usage bias149,150, has been shown to strongly influence heterologous protein 660 
expression levels151,152. 661 
High genomic AT-content is characteristic of the Firmicutes and is reflected in the 662 
nucleotide composition of coding sequences. The Clostridium speǯ codon usage 663 
differs from that of other Firmicutes as well as the Proteobacterium E. coli153 and there 664 
are also bioinformatically observable variations within the Clostridium genus itself154 665 
but the significance of the latter in influencing gene expression has not been 666 
experimentally verified to our knowledge. Genetically encoded reporters have been used 667 
heterologously within the Firmicutes phylum without codon-optimization, for example 668 
Staphylococci have been sources of reporters and antibiotic resistance genes for 669 
Clostridia. On several occasions researchers have successfully used native reporter 670 
genes from E. coli (gusA)63, T. thermosulfurigenes (lacZ)72 and the firefly Photinus pyralis 671 
(lucB)72 (we describe these reporters in more detail in the Enzymatic Reporter Protein 672 
section). Codon-optimized genes for C. difficile have been used in C. acetobutylicum 55, as 673 
well as bespoke C. acetobutylicum codon-optimized ones24,48. Researchers have also 674 
codon-optimized several GFP-like proteins for use in Firmicutes155 (with B. subtilis in 675 
mind) but these have not been used in solventogens to our knowledge.  676 
Codon optimization is not a trivial problem and codon optimization strategies vary 677 
considerably. The codon-adaptation index (CAI)150 has been the historical measure of 678 
codon usage bias in an organism while there are others such as the codon bias index and 679 
the effective number of codons156Ǥǡǯ680 
CAI (making it more like a native gene or a highly expressed native gene) has not been 681 
found to correlate with expression levels157,158. Efforts have been made to improve the 682 
indices describing codon usage bias and translational efficiency (which codon usage bias 683 
is thought to reflect) by studying endogenous gene expression159,160. In addition, 684 
condition-specific usage tables have also been reported161. In an alternative strategy, 685 
Welch and colleagues developed genetic algorithms to select partial least squares 686 
regression models which revealed that codons predominantly read by tRNAs that are 687 
most highly charged during amino acid starvation were good predictors of expression 688 
levels. Based on these results the researchers developed proprietary codon optimization 689 
algorithms to maximize protein expression158,162 which allowed them to predict 690 
expression levels in E. coli.  691 
While it is clear that there is room for improvement in the heterologous protein 692 
expression strategies used in Clostridium solventogens, codon optimization strategies 693 
themselves are still being developed and the underlying principles are not yet fully 694 
understood; progress and existing approaches in the field have been reviewed 695 
elsewhere163. A good starting point is for researchers to report the details of the codon 696 
optimization strategy undertaken when publishing work containing codon-optimized 697 
genes. This way data from heterologous protein expression in solventogens can be 698 
compared more reliably. 699 
Post-transcriptional control of gene expression 700 
 701 
Tuning gene expression levels in Clostridium species has been achieved using control at 702 
the RNA level Ȃ by either influencing translation or changing RNA degradation rates. 703 
Controlling mRNA stability 704 
Another potential avenue for optimisation of expression levels is the adjustment of 705 
mRNA stability. Altering the stability of an mRNA transcript influences the number of 706 
transcripts in the cell, thereby affecting the overall rate of translation. In bacteria, a 707 
number of factors are associated with mRNA stability, such as secondary structures, 708 
RNase recognition sites and polyadenylation, amongst others122. The presence of 709 
secondary structures at the  ?ǯend of the mRNA has been observed to provide an 710 
increase in mRNA stability122. In E. coli, these structures prevent the binding of RNase E, 711 
an endonuclease which binds single-stranded RNA    ?ǯ     712 
cleavage sites. This property has been exploited in E. coli by the generation of libraries of 713        ?ǯuntranslated region (UTR)164. While C. 714 
acetobutylicum has an RNase E homolog, RNase E/G, it is not certain if this behaves in 715 
the same way as E. coli RNase E, due to having a different domain organisation165. 716 
Nevertheless, C. acetobutylicum also has a homolog of RNase Y166, which fulfils the role of 717 
RNase E in B. subtilis167. Correspondingly, the util   ?ǯ    718 
mRNA has been demonstrated in clostridia;   ?ǯ-loop sequences 719 
was confirmed to increase mRNA stability, reporter expression, and expression of the 720 
genes adhE1 and adhE2 in both C. acetobutylicum and C. beijerinckii168. This effect was 721 
much more pronounced during solventogenesis than during acidogenesis. Similarly, the 722 
introduction of a terminator hairpin in  ?ǯ723 
via inhibition of nuclease activity122. Although not fully explored, this principle has been 724 
demonstrated in solventogenic clostridia; the expression of a cat reporter gene in C. 725 
acetobutylicum was observed to increase by approximately 36% when the downstream 726 
adc terminator was replaced by a synthetic terminator, BBa_B1010, from the iGEM 727 
registry168. Additionally, a terminator with activity in the reverse orientation prevents 728 
the formation of antisense transcripts which are known to reduce protein expression 729 
levels169.  730 
 731 
A completely opposite approach is to reduce mRNA stability by introducing RNase sites 732  ?ǯǤ bodies 733 
when overexpressed. In E. coli, sequences derived from the cat gene, which contains 28 734 
RNase E sites, have been shown to reduce mRNA stability170. When combined with two 735 
poorly soluble heterologous enzymes, the cat-  ?ǯ 736 
an increase in soluble protein, with concomitant increases in enzyme activity. The 737 
authors noted that this improvement could not be observed simply by using a weaker 738 
promoter; it was proposed that by limiting the stability of the mRNA, the number of 739 
proteins that could be produced from a single transcript was decreased, thus limiting 740 
the local concentrations of protein during translation.  741 
 742 
Antisense RNAs and Riboswitches 743 
 744 
Bacterial antisense RNAs (asRNAs) are transcripts with complementarity to another 745 
RNA. Several studies have used asRNAs were used to reduce native gene expression in C. 746 
acetobutylicum169,171 and in C. pasteurianum172, demonstrating that multiple routes to 747 
regulate gene expression are available in the solventogenic clostridia. 748 
Riboregulators are another class of naturally-occuring and generally trans-activating 749 
asRNA elements that respond to a signal nucleic acid by Watson-Crick base pairing173. 750 
They have defined sensor and effector domains and have been rationally designed to 751 
repress174 and activate gene expression175 in E. coli. Toehold switches (a synthetic cis-752 
regulatory subgroup of riboregulators) that activate gene expression in the presence of 753 
cognate RNAs rely on sequestering the RBS and start codon176. Like riboswitches, 754 
riboregulators are known to be present in Clostridium genomes. 755 
Riboswitches are RNA sequences that are able to bind to a soluble ligand, influencing the 756 
properties of the RNA. In nature, riboswitches typically contain a binding domain, or 757 ǮǯǡǮǯ177. Binding leads to a 758 
change in conformation of the RNA, leading to formation of a secondary structure which 759 
can act as a terminator or an anti-terminator. While riboswitches are typically found in 760  ?ǯs of mRNAs, some have been recently determined to control the expression of 761 
antisense RNAs or protein-sequestering small RNAs, while yet others have been shown 762 
to control access to recognition sequences such as RNase sites178. The range of 763 
applications has been further developed by the creation of synthetic riboswitches. In 764 
bacteria, riboswitches have been developed that can influence translation initiation by 765 
inhibiting access to the RBS; ligand binding leads to a conformational change or even to 766 
self-cleavage, revealing the RBS and allowing translation179. Riboswitches are found in 767 
all taxa and a number have been characterized in the solventogenic clostridia180Ȃ182. 768 
However, riboswitches have not yet been used in the engineering of these organisms. As 769 
discussed earlier, only a limited range of inducible systems is available for the 770 
engineering of clostridia; the use of synthetic riboswitches could be a promising 771 
alternative for the creation of controlled promoters. 772 
Replication 773 
 774 
Plasmid origins of replication 775 
Four replicons are in routine usage in solventogens: pCB102 (from C. butyricum), pBP1 776 
(from C. botulinum), pCD6 (from C. difficile) and pIM13 (from B. subtilis)96. The pIM13 777 
replication origin is thought to replicate via rolling-circle replication183 while there is 778 
evidence that pCD6 replicates in similar fashion to pIP404184,185 (which is either theta or 779 
strand-displacement). The replication mechanisms of pCB102 and pBP1 are unknown. 780 
In C. acetobutylicumǡ      Ⱦ ?replicon 781 
and the pUB110 replicon186; the pUB110 replicon was found to be somewhat more 782 
stable than pIM13, Ⱦ ?Ǥ The C. beijerinckii 783  ?ǯC. beijerinckii strains187. 784 
Additionally, the development of a replicon specific for C. saccharoperbutylacetonicum 785 
N1-4 was reported in 2007188, this replicon is identical to the origin of the endogenous 786 
plasmid from C. saccharoperbutylacetonicum N1-50415 . A thermosensitive origin 787 
pWV01ts derived from Lactococcus lactis cremoris189 has been shown to work in both C. 788 
ljungdahlii and C. acetobutylicum51. Segregation and transformation frequencies are 789 
available; however, more work is needed to determine copy number and compatibility 790 
groups.  791 
 792 
Chromosomal integration 793 
The      ǡ    Ǯǯ  ǡ   794 
consideration for synthetic biology projects. Genomic integration has several advantages 795 
over plasmid-based expression strategies, including increased stability, removal of the 796 
requirement for antibiotic selection, and standardisation of copy number190Ȃ192. 797 
However, there are other factors that must be considered when using chromosomal 798 
integration. One implication of the integration position is the copy number effect Ȃ genes 799 
closer to the origin have a higher copy number than ones near the terminus in 800 
exponentially dividing cells due to the mechanism of DNA replication. There is 801 
contradictory evidence as to the effects of chromosome location and levels of 802 
expression193,194,195. The cause of some of the apparent transcriptional insulation of 803 
chromosomal genes (and thus promoter independence) was found to be due to the gene 804 
silencing activity of the HU-protein in E. coli194, a protein that is also present in 805 
Firmicutes196. Genomic engineering in E. coli has been carried out extensively; lambda-806 
Red recombineering197 is well-established, and the utility of the newly developed 807 
CRISPR technique has been demonstrated in this species198,199. However, in the 808 
solventogenic clostridia, until recently published examples of genomic integration had 809 
been still somewhat limited. An early enabling technology was ClosTron which adapted 810 
the Ll.LtrB intron for use in Clostridium110. Another method for genomic integration is 811 
Allele-Coupled Exchange (ACE), as demonstrated in C. acetobutylicum24,25,190. This is a 812 
homologous recombination-based method, where homology arms with different lengths 813 
are used to control the sequence of recombination events, and the second recombination 814 
leads to the generation of a selectable phenotype; currently, this involves either the 815 
truncation or repair of the pyrE gene or the activation of a promoterless antibiotic 816 
resistance gene by integration downstream of a strong chromosomal promoter such as 817 
thlA 190. Thus, one potential drawback to this method is that it only allows integration 818 
into a limited selection of loci. This drawback can be mitigated by the ability to carry out 819 
multiple rounds of iterative ACE, thereby making further genomic integrations into the 820 
same locus.  821 
 822 
Nevertheless, many new developments have been made regarding the genetic 823 
manipulation of solventogenic clostridia. A variety of different allelic exchange-based 824 
strategies have been exemplified in C. acetobutylicum101,109,200,201 and C. beijerinckii202; 825 
while most of these studies have focused on the generation of in-frame deletions and 826 
subsequent complementation, Al-Hinai et al.101 demonstrate the integration of a 827 
heterologous gene through gene replacement. Furthermore, the generation of point 828 
mutations through recombineering has been demonstrated in C. acetobutylicum203, 829 
suggesting that the integration of DNA through this method may be feasible. Finally, 830 
mutant selection via CRISPR has been established in almost all of the main solventogenic 831 
species, with published examples in C. beijerinckii121,204, C. acetobutylicum104, C. 832 
pasteurianum205, and C. saccharoperbutylacetonicum206. Future developments are certain 833 
to expand the range of genomic modifications that can be made in these organisms. 834 
 835 
Insulators 836   ǯ          837 
compared to the sequence context in which it was characterized207. This poses a 838 
fundamental challenge to the synthetic biology principle of part creation and 839 
characterization208. To counteract this issue in reproducibility genetic engineers have 840 
started utilizing a new class of parts called insulators209. Several strategies can be 841 
undertaken to insulate a part from its genetic context, and these can be split into two 842 
main categories: DNA-level insulators (such as simply using flanking buffer zones of 843 
sequence without a biological function or secondary structure) and RNA-level 844 
insulators. The latter includes post-transcriptional modification of RNA as well as the 845 
commonly used flanking double terminators123 that prevent read-through transcription 846 
into synthetic gene constructs. Post-transcriptional insulators consist of inclusion of 847 
ribozyme-based insulators or using CRISPR-RNA-     ?ǯ 848 
from the coding sequence (CDS)208,210. 849 
Different parts require different types of insulation in order to achieve maximum 850 
reproducibility without compromising features such as strength.  851 
Promoters used in synthetic biology projects are often minimal (-35 to -10 region) and 852 
without characterized transcriptional start sites; the inclusion of important functional 853 
elements such as the UP element has been previously recommended.211 Accordingly, the 854 
addition of an upstream and downstream insulating sequence has increased 855 
reproducibility in different genetic contexts212. It is worth noting that the strong 856 
Clostridium promoters that are in widespread use in the Clostridium community, fdx and 857 
thlA, are 200 and 150bp respectively. Even though this recombinant thlA is longer than a 858 
usual  ǡ    ?ǯ    ǯ  ȋrecombinant 859 
thlA is 59bp from its  ?ǯ   Ȍǡ  recombinant  ?ǯ860 
end is slightly truncated to exclude a Rex NADH-dependent regulator binding site (as 861 
mentioned before). A study that reported the use of a minimal thlA promoter in C. 862 
acetobutylicum, miniPthl which has a  ?ǯǡdid not test activity variation in 863 
different genetic contexts91.  864 
Work in E. coli has demonstrated the utility ǯǯǡa leader peptide 865 
is translationally coupled with the CDS of interest, in improving reliability and context 866 
independence (downstream gene sequence)  ?ǯ867 
a new coding sequence212. An upstream RBS and start codon initiate translation of the 868 
leader peptide, the stop codon of which overlaps with the start of the downstream CDS, 869   ǯ  . The ribosomes translating 870       ?ǯ  ȋ   Ȍǡ   871 
forming secondary structures with the mRNA of the downstream CDS and thus 872 
influencing translation. The same study employed standard transcriptional start site 873 ȋǲ ? ?ǳȌǣ ?ǯȋȌunforeseen effects of 874  ?ǯǤ 875 
As mentioned above, the observation of ribosomal repression of transcription 876         ǯǯ   877 
sequence without emergent function and secondary structure to separate the stop 878 
codon and the stem-loop hairpin126. Such strategies are yet to be implemented in 879 
Clostridium engineering projects. 880 
 881 
Discussion 882 
The development of biorenewables as an alternative to petroleum-derived commodity 883 
chemicals and fuels has resulted in the emergence of new markets213. Increasing 884 
productivity, broadening the range of feedstocks, improving tolerance to solvents and 885 
by-products are all existing challenges to achieving higher sustainability and ensuring 886 
the economic viability of Clostridium-derived biorenewables214. Clostridium species 887 
remain important hosts for the biological production of solvents and their further 888 
development relies on the adaptation of novel methodologies such as synthetic biology 889 
and metabolic engineering. Much progress has been made in the latter with several 890 
projects improving industrially relevant strains; however, the availability of biological 891 
parts with known behaviour is one of the limiting factors for the rate and scale of 892 
research. The reasons for our anticipation are twofold: first, the physical availability of 893 
biological parts streamlines assembly of genetic pathways, and second, knowledge about 894 ǯ            895 
genetic circuits. We have shown in this review that there are multiple areas where 896 
improved knowledge of parts would provide a better toolkit for synthetic biologists 897 
using these organisms and consequently improve the rate at which industrial 898 
biotechnology and bioenergy process development can improve.  899 
References 900 
 901 
ȋ ?ȌǡǤǤǡǡǤ
ǤǤǡǡǤǤȋ ? ? ? ?Ȍǯ902 
determinative bacteriology 7th ed. Williams & Wilkins Co., Baltimore. 903 
(2) Jones, D. T., and Woods, D. R. (1986) Acetone-butanol fermentation revisited. 904 
Microbiol. Rev. 50, 484Ȃ524. 905 
(3) Gheshlaghi, R., Scharer, J. M., Moo-Young, M., and Chou, C. P. (2009) Metabolic 906 
pathways of clostridia for producing butanol. Biotechnol. Adv. 27, 764Ȃ781. 907 
(4) Keis, S., Bennett, C. F., Ward, V. K., and Jones, D. T. (1995) Taxonomy and phylogeny 908 
of industrial solvent-producing clostridia. Int. J. Syst. Bacteriol. 45, 693Ȃ705. 909 
(5) Keis, S., Shaheen, R., and Jones, D. T. (2001) Emended descriptions of Clostridium 910 
acetobutylicum and Clostridium beijerinckii, and descriptions of Clostridium 911 
saccharoperbutylacetonicum sp. nov. and Clostridium saccharobutylicum sp. nov. Int. J. 912 
Syst. Evol. Microbiol. 51, 2095Ȃ2103. 913 
(6) Hellinger, E. (1947) Clostridium aurantibutyricum (n.sp.): A Pink Butyric Acid 914 
Clostridium. J. Gen. Microbiol. 1, 203Ȃ210. 915 
(7) Holt, R. A., Cairns, A. J., and Morris, J. G. (1988) Production of butanol by Clostridium 916 
puniceum in batch and continuous culture. Appl. Microbiol. Biotechnol. 27, 319Ȃ324. 917 
(8) Abd-Alla, M. H., Zohri, A. N. A., El-Enany, A. W. E., and Ali, S. M. (2015) Acetone-918 
butanol-ethanol production from substandard and surplus dates by Egyptian native 919 
Clostridium strains. Anaerobe 32, 77Ȃ86. 920 
(9) Sarchami, T., Munch, G., Johnson, E., Kießlich, S., and Rehmann, L. (2016) A Review of 921 
Process-Design Challenges for Industrial Fermentation of Butanol from Crude Glycerol 922 
by Non-Biphasic Clostridium pasteurianum. Fermentation 2, 13. 923 
(10) Tashiro, Y., Yoshida, T., Noguchi, T., and Sonomoto, K. (2013) Recent advances and 924 
future prospects for increased butanol production by acetone-butanol-ethanol 925 
fermentation. Eng. Life Sci. 13, 432Ȃ445. 926 
(11) Tamura, K., and Nei, M. (1993) Estimation of the number of nucleotide substitutions 927 
in the control region of mitochondrial DNA in humans and chimpanzees. Mol. Biol. Evol. 928 
10, 512Ȃ26. 929 
(12) Felsenstein, J. (1985) Confidence Limits on Phylogenies: An Approach Using the 930 
Bootstrap. Evolution (N. Y). 39, 783Ȃ791. 931 
(13) Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., and Kumar, S. (2011) 932 
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, 933 
evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28, 2731Ȃ9. 934 
(14) ABAS. (2015) Classification of prokaryotes (bacteria and archaea) into risk groups 935 
(TRBA 466). Bundesarbeitsblatt. http://www.baua.de 19. 936 
(15) Poehlein, A., Solano, J. D. M., Flitsch, S. K., Krabben, P., Winzer, K., Reid, S. J., Jones, D. 937 
T., Green, E., Minton, N. P., Daniel, R., and Dürre, P. (2017) Microbial solvent formation 938 
revisited by comparative genome analysis. Biotechnol. Biofuels 10, 58. 939 
(16) Udaondo, Z., Duque, E., and Ramos, J. L. (2017) The pangenome of the genus 940 
Clostridium. Environ. Microbiol. 19, 2588Ȃ2603. 941 
(17) Shaheen, R., Shirley, M., and Jones, D. T. (2000) Comparative fermentation studies of 942 
industrial strains belonging to four species of solvent-producing clostridia. J. Mol. 943 
Microbiol. Biotechnol. 2, 115Ȃ124. 944 
(18) Jang, Y.-S., Lee, J. Y., Lee, J., Park, J. H., Im, J. A., Eom, M.-H., Lee, J., Lee, S.-H., Song, H., 945 
Cho, J.-H., Seung, D. Y., and Lee, S. Y. (2012) Enhanced butanol production obtained by 946 
reinforcing the direct butanol-forming route in Clostridium acetobutylicum. MBio 3, 947 
e00314-12. 948 
(19) Pyne, M. E., Sokolenko, S., Liu, X., Srirangan, K., Bruder, M. R., Aucoin, M. G., Moo-949 
Young, M., Chung, D. A., and Chou, C. P. (2016) Disruption of the reductive 1,3-950 
propanediol pathway triggers production of 1,2-propanediol for sustained glycerol 951 
fermentation by Clostridium pasteurianum. Appl. Environ. Microbiol. 82, 5375Ȃ5388. 952 
(20) Xiao, H., Li, Z., Jiang, Y., Yang, Y., Jiang, W., Gu, Y., and Yang, S. (2012) Metabolic 953 
engineering of D-xylose pathway in Clostridium beijerinckii to optimize solvent 954 
production from xylose mother liquid. Metab. Eng. 14, 569Ȃ578. 955 
(21) Xiao, H., Gu, Y., Ning, Y., Yang, Y., Mitchell, W. J., Jiang, W., and Yang, S. (2011) 956 
Confirmation and elimination of xylose metabolism bottlenecks in glucose 957 
phosphoenolpyruvate-dependent phosphotransferase system-deficient Clostridium 958 
acetobutylicum for simultaneous utilization of glucose, xylose, and arabinose. Appl. 959 
Environ. Microbiol. 77, 7886Ȃ7895. 960 
(22) Mingardon, F., Chanal, A., Tardif, C., and Fierobe, H. P. (2011) The issue of secretion 961 
in heterologous expression of Clostridium cellulolyticum cellulase-encoding genes in 962 
Clostridium acetobutylicum ATCC 824. Appl. Environ. Microbiol. 77, 2831Ȃ2838. 963 
(23) Chanal, A., Mingardon, F., Bauzan, M., Tardif, C., and Fierobe, H. P. (2011) Scaffoldin 964 ǲǳ965 
cellulosomal cellulases by Clostridium acetobutylicum. Appl. Environ. Microbiol. 77, 6277Ȃ966 
6280. 967 
(24) Kovács, K., Willson, B. J., Schwarz, K., Heap, J. T., Jackson, A., Bolam, D. N. N., Winzer, 968 
K., and Minton, N. P. (2013) Secretion and assembly of functional mini-cellulosomes 969 
from synthetic chromosomal operons in Clostridium acetobutylicum ATCC 824. 970 
Biotechnol. Biofuels 6, 117. 971 
(25) Willson, B. J., Kovács, K., Wilding-Steele, T., Markus, R., Winzer, K., and Minton, N. P. 972 
(2016) Production of a functional cell wall-anchored minicellulosome by recombinant 973 
Clostridium acetobutylicum ATCC 824. Biotechnol. Biofuels 9, 109. 974 
(26) Collas, F., Kuit, W., Clément, B., Marchal, R., López-Contreras, A. M., and Monot, F. 975 
(2012) Simultaneous production of isopropanol, butanol, ethanol and 2,3-butanediol by 976 
Clostridium acetobutylicum ATCC 824 engineered strains. AMB Express 2, 45. 977 
(27) González-Pajuelo, M., Meynial-Salles, I., Mendes, F., Andrade, J. C., Vasconcelos, I., 978 
and Soucaille, P. (2005) Metabolic engineering of Clostridium acetobutylicum for the 979 
industrial production of 1,3-propanediol from glycerol. Metab. Eng. 7, 329Ȃ336. 980 
(28) Cai, X., and Bennett, G. N. (2011) Improving the Clostridium acetobutylicum butanol 981 
fermentation by engineering the strain for co-production of riboflavin. J. Ind. Microbiol. 982 
Biotechnol. 38, 1013Ȃ1025. 983 
(29) Quinn, J. Y., Cox, R. S., Adler, A., Beal, J., Bhatia, S., Cai, Y., Chen, J., Clancy, K., 984 
Galdzicki, M., Hillson, N. J., Le Novère, N., Maheshwari, A. J., McLaughlin, J. A., Myers, C. J., 985 
Umesh, P., Pocock, M., Rodriguez, C., Soldatova, L., Stan, G. B. V., Swainston, N., Wipat, A., 986 
and Sauro, H. M. (2015) SBOL Visual: A Graphical Language for Genetic Designs. PLoS 987 
Biol. 13, e1002310. 988 
(30) Mermelstein, L. D., and Papoutsakis, E. T. (1993) In vivo methylation in Escherichia 989 
coli by the Bacillus subtilis phage BA3T I methyltransferase to protect plasmids from 990 
restriction upon transformation of Clostridium acetobutylicum ATCC 824. Appl. Environ. 991 
Microbiol. 59, 1077Ȃ1081. 992 
(31) Nölling, J., Breton, G., Omelchenko, M. V, Makarova, K. S., Zeng, Q., Gibson, G., Hong 993 
Mei Lee, Dubois, J., Qiu, D., Hitti, J., Aldredge, T., Ayers, M., Bashirzadeh, R., Bochner, H., 994 
Boivin, M., Bross, S., Bush, D., Butler, C., Caron, A., Caruso, A., Cook, R., Daggett, P., 995 
Deloughery, C., Egan, J., Ellston, D., Engelstein, M., Ezedi, J., Gilbert, K., Goyal, A., Guerin, J., 996 
Ho, T., Holtham, K., Joseph, P., Keagle, P., Kozlovsky, J., LaPlante, M., LeBlanc, G., Lumm, 997 
W., Majeski, A., McDougall, S., Mank, P., Mao, J. I., Nocco, D., Patwell, D., Phillips, J., Pothier, 998 
B., Prabhakar, S., Richterich, P., Rice, P., Rosetti, D., Rossetti, M., Rubenfield, M., Sachdeva, 999 
M., Snell, P., Spadafora, R., Spitzer, L., Shimer, G., Thomann, H. U., Vicaire, R., Wall, K., 1000 
Wang, Y., Weinstock, K., Lai Peng Wong, Wonsey, A., Xu, Q., Zhang, L., Wolf, Y. I., Tatusov, 1001 
R. L., Sabathe, F., Doucette-Stamm, L., Soucaille, P., Daly, M. J., Bennett, G. N., Koonin, E. V, 1002 
and Smith, D. R. (2001) Genome sequence and comparative analysis of the solvent-1003 
producing bacterium Clostridium acetobutylicum. J. Bacteriol. 183, 4823Ȃ4838. 1004 
(32) Oultram, J. D., Loughlin, M., Swinfield, T.-J. J., Brehm, J. K., Thompson, D. E., and 1005 
Minton, N. P. (1988) Introduction of plasmids into whole cells of Clostridium 1006 
acetobutylicum by electroporation. FEMS Microbiol. Lett. 56, 83Ȃ88. 1007 
(33) Pyne, M. E., Moo-Young, M., Chung, D. A., and Chou, C. P. (2013) Development of an 1008 
electrotransformation protocol for genetic manipulation of Clostridium pasteurianum. 1009 
Biotechnol. Biofuels 6, 50. 1010 
(34) Lesiak, J. M., Liebl, W., and Ehrenreich, A. (2014) Development of an in vivo 1011 
methylation system for the solventogen Clostridium saccharobutylicum NCP 262 and 1012 
analysis of two endonuclease mutants. J. Biotechnol. 188, 97Ȃ99. 1013 
(35) Herman, N. A., Li, J., Bedi, R., Turchi, B., Liu, X., Miller, M. J., and Zhang, W. (2017) 1014 
Development of a High-Efficiency Transformation Method and Implementation of 1015 
Rational Metabolic Engineering for the Industrial Butanol Hyperproducer Clostridium 1016 
saccharoperbutylacetonicum Strain N1-4. Appl. Environ. Microbiol. 83, AEM.02942-16. 1017 
(36) Grosse-Honebrink, A., Schwarz, K. M., Wang, H., Minton, N. P., and Zhang, Y. (2017) 1018 
Improving gene transfer in Clostridium pasteurianum through the isolation of rare 1019 
hypertransformable variants. Anaerobe 48, 203Ȃ205. 1020 
(37) Kolek, J., Sedlar, K., Provaznik, I., and Patakova, P. (2016) Dam and Dcm 1021 
methylations prevent gene transfer into Clostridium pasteurianum NRRL B-598: 1022 
development of methods for electrotransformation, conjugation, and sonoporation. 1023 
Biotechnol. Biofuels 9, 14. 1024 
(38) Oh, Y. H., Eom, G. T., Kang, K. H., Choi, J. W., Song, B. K., Lee, S. H., and Park, S. J. 1025 
(2015) Optimized Transformation of Newly Constructed Escherichia coli-Clostridia 1026 
Shuttle Vectors into Clostridium beijerinckii. Appl. Biochem. Biotechnol. 177, 226Ȃ236. 1027 
(39) Pyne, M. E., Bruder, M., Moo-Young, M., Chung, D. A., and Chou, C. P. (2014) 1028 
Technical guide for genetic advancement of underdeveloped and intractable Clostridium. 1029 
Biotechnol. Adv. 32, 623Ȃ641. 1030 
(40) Minton, N. P., Ehsaan, M., Humphreys, C. M., Little, G. T., Baker, J., Henstra, A. M., 1031 
Liew, F., Kelly, M. L., Sheng, L., Schwarz, K., and Zhang, Y. (2016) A roadmap for gene 1032 
system development in Clostridium. Anaerobe 41, 104Ȃ112. 1033 
(41) Shaner, N. C., Steinbach, P. A., and Tsien, R. Y. (2005) A guide to choosing 1034 
fluorescent proteins. Nat. Methods 2, 905Ȃ909. 1035 
(42) Drepper, T., Eggert, T., Circolone, F., Heck, A., Krauß, U., Guterl, J.-K., Wendorff, M., 1036 
Losi, A., Gärtner, W., and Jaeger, K.-E. (2007) Reporter proteins for in vivo fluorescence 1037 
without oxygen. Nat. Biotechnol. 25, 443Ȃ445. 1038 
(43) Jean, D., Briolat, V., and Reysset, G. (2004) Oxidative stress response in Clostridium 1039 
perfringens. Microbiology 150, 1649Ȃ1659. 1040 
(44) Hartman, A. H., Liu, H., and Melville, S. B. (2011) Construction and Characterization 1041 
of a Lactose-Inducible Promoter System for Controlled Gene Expression in Clostridium 1042 
perfringens. Appl. Environ. Microbiol. 77, 471Ȃ478. 1043 
(45) Ransom, E. M., Williams, K. B., Weiss, D. S., and Ellermeier, C. D. (2014) 1044 
Identification and characterization of a gene cluster required for proper rod shape, cell 1045 
division, and pathogenesis in Clostridium difficile. J. Bacteriol. 196, 2290Ȃ2300. 1046 
(46) Ransom, E. M., Ellermeier, C. D., and Weiss, D. S. (2015) Use of mCherry red 1047 
fluorescent protein for studies of protein localization and gene expression in Clostridium 1048 
difficile. Appl. Environ. Microbiol. 81, 1652Ȃ1660. 1049 
(47) Ransom, E. M., Weiss, D. S., and Ellermeier, C. D. (2016) Use of mCherryOpt 1050 
fluorescent protein in Clostridium difficile. Methods Mol. Biol. 1476, 53Ȃ67. 1051 
(48) Schulz, F. (2013) Fluoreszenzproteine in Clostridium acetobutylicum - Ein neues in 1052 
vivo Reportersystem. Universität Rostock. 1053 
(49) Li, Y., Xu, T., Tschaplinski, T. J., Engle, N. L., Yang, Y., Graham, D. E., He, Z., and Zhou, J. 1054 
(2014) Improvement of cellulose catabolism in Clostridium cellulolyticum by sporulation 1055 
abolishment and carbon alleviation. Biotechnol. Biofuels 7, 25. 1056 
(50) Bruder, M. R., Pyne, M. E., Moo-Young, M., Chung, D. A., and Chou, C. P. (2016) 1057 
Extending CRISPR-Cas9 technology from genome editing to transcriptional engineering 1058 
in the genus Clostridium. Appl. Environ. Microbiol. 82, 6109Ȃ6119. 1059 
(51) Molitor, B., Kirchner, K., Henrich, A. W., Schmitz, S., and Rosenbaum, M. A. (2016) 1060 
Expanding the molecular toolkit for the homoacetogen Clostridium ljungdahlii. Sci. Rep. 1061 
6, 31518. 1062 
(52) Chapman, S., Faulkner, C., Kaiserli, E., Garcia-Mata, C., Savenkov, E. I., Roberts, A. G., 1063 
Oparka, K. J., and Christie, J. M. (2008) The photoreversible fluorescent protein iLOV 1064 
outperforms GFP as a reporter of plant virus infection. Proc. Natl. Acad. Sci. 105, 20038Ȃ1065 
20043. 1066 
(53) Christie, J. M., Hitomi, K., Arvai, A. S., Hartfield, K. a., Mettlen, M., Pratt, A. J., Tainer, J. 1067 
a., and Getzoff, E. D. (2012) Structural tuning of the fluorescent protein iLOV for 1068 
improved photostability. J. Biol. Chem. 287, 22295Ȃ22304. 1069 
(54) Gawthorne, J. A., Reddick, L. E., Akpunarlieva, S. N., Beckham, K. S. H., Christie, J. M., 1070 
Alto, N. M., Gabrielsen, M., and Roe, A. J. (2012) Express Your LOV: An Engineered 1071 
Flavoprotein as a Reporter for Protein Expression and Purification. PLoS One 7, e52962. 1072 
(55) Buckley, A. M., Jukes, C., Candlish, D., Irvine, J. J., Spencer, J., Fagan, R. P., Roe, A. J., 1073 
Christie, J. M., Fairweather, N. F., and Douce, G. R. (2016) Lighting Up Clostridium difficile: 1074 
Reporting Gene Expression Using Fluorescent Lov Domains. Sci. Rep. 6, 23463. 1075 
(56) Khrenova, M. G., Nemukhin, A. V., and Domratcheva, T. (2015) Theoretical 1076 
characterization of the flavin-based fluorescent protein iLOV and its Q489K mutant. J. 1077 
Phys. Chem. B 119, 5176Ȃ5183. 1078 
(57) Davari, M. D., Kopka, B., Wingen, M., Bocola, M., Drepper, T., Jaeger, K. E., 1079 
Schwaneberg, U., and Krauss, U. (2016) Photophysics of the LOV-Based Fluorescent 1080 
Protein Variant iLOV-Q489K Determined by Simulation and Experiment. J. Phys. Chem. B 1081 
120, 3344Ȃ3352. 1082 
(58) Bullifent, H. L., Moir, A., and Titball, R. W. (1995) The construction of a reporter 1083 
system and use for the investigation of Clostridium perfringens gene expression. FEMS 1084 
Microbiol. Lett. 131, 99Ȃ105. 1085 
(59) Zhang, Y., Grosse-Honebrink, A., and Minton, N. P. (2015) A universal mariner 1086 
transposon system for forward genetic studies in the genus Clostridium. PLoS One 10, 1087 
e0122411. 1088 
(60) Shaw, W. V. (1975) Chloramphenicol acetyltransferase from chloramphenicol-1089 
resistant bacteria. Methods Enzymol. 43, 737Ȃ755. 1090 
(61) Roberts, M. C., Swenson, C. D., Owens, L. M., and Smith, A. L. (1980) Characterization 1091 
of chloramphenicol-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 18, 1092 
610Ȃ615. 1093 
(62) Tummala, S. B., Welker, N. E., and Papoutsakis, E. T. (1999) Development and 1094 
characterization of a gene expression reporter system for Clostridium acetobutylicum 1095 
ATCC 824. Appl. Environ. Microbiol. 65, 3793Ȃ3799. 1096 
(63) Girbal, L., Mortier-Barrière, I., Raynaud, F., Rouanet, C., Croux, C., and Soucaille, P. 1097 
(2003) Development of a sensitive gene expression reporter system and an inducible 1098 
promoter-repressor system for Clostridium acetobutylicum. Appl. Environ. Microbiol. 69, 1099 
4985Ȃ4988. 1100 
(64) Moberg, L. J. (1985) Fluorogenic assay for rapid detection of Escherichia coli in food. 1101 
Appl. Environ. Microbiol. 50, 1383Ȃ1387. 1102 
(65) Sabathé, F., Croux, C., Cornillot, E., and Soucaille, P. (2002) amyP, a reporter gene to 1103 
study strain degeneration in Clostridium acetobutylicum ATCC 824. FEMS Microbiol. Lett. 1104 
210, 93Ȃ98. 1105 
(66) Oliveira Paiva, A. M., Friggen, A. H., Hossein-Javaheri, S., and Smits, W. K. (2016) The 1106 
Signal Sequence of the Abundant Extracellular Metalloprotease PPEP-1 Can Be Used to 1107 
Secrete Synthetic Reporter Proteins in Clostridium difficile. ACS Synth. Biol. 5, 1376Ȃ1108 
1382. 1109 
(67) Quixley, K. W., and Reid, S. J. (2000) Construction of a reporter gene vector for 1110 
Clostridium beijerinckii using a Clostridium endoglucanase gene. J. Mol. Microbiol. 1111 
Biotechnol. 2, 53Ȃ7. 1112 
(68) Oh, Y. H., Eom, G. T., Kang, K. H., Joo, J. C., Jang, Y. A., Choi, J. W., Song, B. K., Lee, S. H., 1113 
and Park, S. J. (2016) Construction of heterologous gene expression cassettes for the 1114 
development of recombinant Clostridium beijerinckii. Bioprocess Biosyst. Eng. 39, 555Ȃ1115 
563. 1116 
(69) Gilham, D., and Lehner, R. (2005) Techniques to measure lipase and esterase 1117 
activity in vitro. Methods 36, 139Ȃ147. 1118 
(70) Hassan, E. A., Abd-Alla, M. H., Bagy, M. M. K., and Morsy, F. M. (2015) In situ 1119 
hydrogen, acetone, butanol, ethanol and microdiesel production by Clostridium 1120 
acetobutylicum ATCC 824 from oleaginous fungal biomass. Anaerobe 34, 125Ȃ131. 1121 
(71) Edwards, A. N., Pascual, R. A., Childress, K. O., Nawrocki, K. L., Woods, E. C., and 1122 
McBride, S. M. (2015) An alkaline phosphatase reporter for use in Clostridium difficile. 1123 
Anaerobe 32, 98Ȃ104. 1124 
(72) Feustel, L., Nakotte, S., and Dürre, P. (2004) Characterization and development of 1125 
two reporter gene systems for Clostridium acetobutylicum. Appl. Environ. Microbiol. 70, 1126 
798Ȃ803. 1127 
(73) Potzkei, J., Kunze, M., Drepper, T., Gensch, T., Jaeger, K.-E., and Buechs, J. (2012) 1128 
Real-time determination of intracellular oxygen in bacteria using a genetically encoded 1129 
FRET-based biosensor. BMC Biol. 10, 28. 1130 
(74) Martin, L., Che, A., and Endy, D. (2009) Gemini, a bifunctional enzymatic and 1131 
fluorescent reporter of gene expression. PLoS One 4. 1132 
ȋ ? ?ȌǡǤǡǡǤǡǡǤǡǡ
Ǥȋ ? ? ? ?ȌȾ-1133 Ƚ-complementation system for molecular cloning in Bacillus subtilis. Gene 1134 
93, 41Ȃ47. 1135 
(76) Knipfer, N., Nooruddin, L., and Shrader, T. E. (1998) Development of an alpha-1136 
complementation system for mycobacterial promoter analysis. Gene 217, 69Ȃ75. 1137 
(77) Volkov, I. Y., Lunina, N. A., Berezina, O. V., Velikodvorskaya, G. A., and Zverlov, V. V. 1138 
(2005) Thermoanaerobacter ethanolicus Ƚ- Ⱦ-1139 
galactosidase genes melA and lacA and properties of recombinant LacA. Mol. Biol. 39, 1140 
799Ȃ805. 1141 
(78) Huber, R. E., Roth, N. J., and Bahl, H. (1996) Quaternary structure, Mg2+ 1142 
interactions, and some kinetic propeȾ-galactosidase from 1143 
Thermoanaerobacterium thermosulfurigenes EM1. J. Protein Chem. 15, 621Ȃ629. 1144 
(79) Browning, D. F., and Busby, S. J. W. (2004) The regulation of bacterial transcription 1145 
initiation. Nat. Rev. Microbiol. 2, 57Ȃ65. 1146 
(80) Helmann, J. D., and Chamberlin, M. J. (1988) Structure and function of bacterial 1147 
sigma factors. Annu. Rev. Biochem. 57, 839Ȃ872. 1148 
(81) Sauer, U., Santangelo, J. D., Treuner, A., Buchholz, M., and Dürre, P. (1995) Sigma 1149 
factor and sporulation genes in Clostridium. FEMS Microbiol. Rev. 17, 331Ȃ340. 1150 
(82) Estrem, S. T., Gaal, T., Ross, W., and Gourse, R. L. (1998) Identification of an UP 1151 
element consensus sequence for bacterial promoters. Biochemistry 95, 9761Ȃ9766. 1152 
(83) Kumar, A., Malloch, R. A., Fujita, N., Smillie, D. A., Ishihama, A., and Hayward, R. S. 1153 
(1993) The minus 35-recognition region of Escherichia coli sigma 70 is inessential for 1154 ǲ ? ?ǳǤJ. Mol. Biol. 232, 406Ȃ18. 1155 
(84) Sinoquet, C., Demey, S., and Braun, F. (2008) Large-scale computational and 1156 
statistical analyses of high transcription potentialities in 32 prokaryotic genomes. 1157 
Nucleic Acids Res. 36, 3332Ȃ3340. 1158 
(85) Katayama, S., Matsushita, O., Jung, C. M., Minami, J., and Okabe, A. (1999) Promoter 1159 
upstream bent DNA activates the transcription of the Clostridium perfringens 1160 
phospholipase C gene in a low temperature-dependent manner. EMBO J. 18, 3442Ȃ3450. 1161 
(86) Graves, M. C., and Rabinowitz, J. C. (1986) In vivo and in vitro transcription of the 1162 
Clostridium pasteurianum Ǥǲǳ1163 
in gram-positive organisms. J. Biol. Chem. 261, 11409Ȃ15. 1164 
(87) Pyne, M. E. (2014, April) Development of genetic tools for metabolic engineering of 1165 
Clostridium pasteurianum. University of Waterloo. 1166 
(88) Wiesenborn, D. P., Rudolph, F. B., and Papoutsakis, E. T. (1988) Thiolase from 1167 
Clostridium acetobutylicum ATCC 824 and Its Role in the Synthesis of Acids and Solvents. 1168 
Appl Env. Microbiol 54, 2717Ȃ2722. 1169 
(89) Stim-Herndon, K. P., Petersen, D. J., and Bennett, G. N. (1995) Characterization of an 1170 
acetyl-CoA C-acetyltransferase (thiolase) gene from Clostridium acetobutylicum ATCC 1171 
824. Gene, pp 81Ȃ85. 1172 
(90) Bormann, S., Baer, Z. C., Sreekumar, S., Kuchenreuther, J. M., Dean Toste, F., Blanch, 1173 
H. W., and Clark, D. S. (2014) Engineering Clostridium acetobutylicum for production of 1174 
kerosene and diesel blendstock precursors. Metab. Eng. 25, 124Ȃ130. 1175 
(91) Dong, H., Tao, W., Zhang, Y., and Li, Y. (2012) Development of an 1176 
anhydrotetracycline-inducible gene expression system for solvent-producing 1177 
Clostridium acetobutylicum: A useful tool for strain engineering. Metab. Eng. 14, 59Ȃ67. 1178 
(92) Perret, S., Casalot, L., Fierobe, H. P., Tardif, C., Sabathe, F., Belaich, J. P., and Belaich, 1179 
A. (2004) Production of Heterologous and Chimeric Scaffoldins by Clostridium 1180 
acetobutylicum ATCC 824. J. Bacteriol. 186, 253Ȃ257. 1181 
(93) Mingardon, F., Perret, S., Bélaïch, A., Tardif, C., Bélaïch, J. P., and Fierobe, H. P. (2005) 1182 
Heterologous production, assembly, and secretion of a minicellulosome by Clostridium 1183 
acetobutylicum ATCC 824. Appl. Environ. Microbiol. 71, 1215Ȃ1222. 1184 
(94) Wietzke, M., and Bahl, H. (2012) The redox-sensing protein Rex, a transcriptional 1185 
regulator of solventogenesis in Clostridium acetobutylicum. Appl. Microbiol. Biotechnol. 1186 
96, 749Ȃ761. 1187 
(95) Zhang, L., Nie, X., Ravcheev, D. A., Rodionov, D. A., Sheng, J., Gu, Y., Yang, S., Jiang, W., 1188 
and Yang, C. (2014) Redox-responsive repressor rex modulates alcohol production and 1189 
oxidative stress tolerance in Clostridium acetobutylicum. J. Bacteriol. 196, 3949Ȃ3963. 1190 
(96) Heap, J. T., Pennington, O. J., Cartman, S. T., and Minton, N. P. (2009) A modular 1191 
system for Clostridium shuttle plasmids. J. Microbiol. Methods 78, 79Ȃ85. 1192 
(97) Novichkov, P. S., Kazakov, A. E., Ravcheev, D. A., Leyn, S. A., Kovaleva, G. Y., Sutormin, 1193 
R. A., Kazanov, M. D., Riehl, W., Arkin, A. P., Dubchak, I., and Rodionov, D. A. (2013) 1194 
RegPrecise 3.0--a resource for genome-scale exploration of transcriptional regulation in 1195 
bacteria. BMC Genomics 14, 745. 1196 
(98) Wang, Y., Zhang, Z.-T., Seo, S.-O., Lynn, P., Lu, T., Jin, Y.-S., and Blaschek, H. P. (2016) 1197 
Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9. Biotechnol. 1198 
Bioeng. 113, 2739Ȃ2743. 1199 
(99) Pyne, M. E., Moo-Young, M., Chung, D. A., and Chou, C. P. (2014) Expansion of the 1200 
genetic toolkit for metabolic engineering of Clostridium pasteurianum: chromosomal 1201 
gene disruption of the endogenous CpaAI restriction enzyme. Biotechnol. Biofuels 7, 163. 1202 
(100) Wang, Y., Li, X., Mao, Y., and Blaschek, H. P. (2012) Genome-wide dynamic 1203 
transcriptional profiling in Clostridium beijerinckii NCIMB 8052 using single-nucleotide 1204 
resolution RNA-Seq. BMC Genomics 13, 102. 1205 
(101) Al-Hinai, M. A., Fast, A. G., and Papoutsakis, E. T. (2012) Novel system for efficient 1206 
isolation of Clostridium double-crossover allelic exchange mutants enabling markerless 1207 
chromosomal gene deletions and DNA integration. Appl. Environ. Microbiol. 78, 8112Ȃ1208 
8121. 1209 
(102) Garcia, H. G., Sanchez, A., Boedicker, J. Q., Osborne, M., Gelles, J., Kondev, J., and 1210 
Phillips, R. (2012) Operator sequence alters gene expression independently of 1211 
transcription factor occupancy in bacteria. Cell Rep. 2, 150Ȃ161. 1212 
(103) Zong, Y., Zhang, H. M., Lyu, C., Ji, X., Hou, J., Guo, X., Ouyang, Q., and Lou, C. (2017) 1213 
Insulated transcriptional elements enable precise design of genetic circuits. Nat. 1214 
Commun. 8, 52. 1215 
(104) Li, Q., Chen, J., Minton, N. P., Zhang, Y., Wen, Z., Liu, J., Yang, H., Zeng, Z., Ren, X., 1216 
Yang, J., Gu, Y., Jiang, W., Jiang, Y., and Yang, S. (2016) CRISPR-based genome editing and 1217 
expression control systems in Clostridium acetobutylicum and Clostridium beijerinckii. 1218 
Biotechnol. J. 11, 961Ȃ972. 1219 
(105) Tabor, S., and Richardson, C. C. (1985) A bacteriophage T7 RNA 1220 
polymerase/promoter system for controlled exclusive expression of specific genes (T7 1221 Ȁ ? ?ȀȀȾ-lactamase/rifampicin). Biochemistry 1222 
82, 1074Ȃ1078. 1223 
(106) McLaughlin, J. R., Murray, C. L., and Rabinowitz, J. C. (1981) Unique features in the 1224 
ribosome binding site sequence of the gram-positive Staphylococcus aureus beta-1225 
lactamase gene. J. Biol. Chem. 256, 11283Ȃ91. 1226 
(107) Lamberte, L. E., Baniulyte, G., Singh, S. S., Stringer, A. M., Bonocora, R. P., Stracy, M., 1227 
Kapanidis, A. N., Wade, J. T., and Grainger, D. C. (2017) Horizontally acquired AT-rich 1228 
genes in Escherichia coli cause toxicity by sequestering RNA polymerase. Nat. Microbiol. 1229 
2, 16249. 1230 
(108) Heap, J. T., Kuehne, S. A., Ehsaan, M., Cartman, S. T., Cooksley, C. M., Scott, J. C., and 1231 
Minton, N. P. (2010) The ClosTron: Mutagenesis in Clostridium refined and streamlined. 1232 
J. Microbiol. Methods 80, 49Ȃ55. 1233 
(109) Ehsaan, M., Kuit, W., Zhang, Y., Cartman, S. T., Heap, J. T., Winzer, K., and Minton, N. 1234 
P. (2016) Mutant generation by allelic exchange and genome resequencing of the 1235 
biobutanol organism Clostridium acetobutylicum ATCC 824. Biotechnol. Biofuels 9, 4. 1236 
(110) Heap, J. T., Pennington, O. J., Cartman, S. T., Carter, G. P., and Minton, N. P. (2007) 1237 
The ClosTron: A universal gene knock-out system for the genus Clostridium. J. Microbiol. 1238 
Methods 70, 452Ȃ464. 1239 
(111) Geissendörfer, M., and Hillen, W. (1990) Regulated expression of heterologous 1240 
genes in Bacillus subtilis using the Tn10 encoded tet regulatory elements. Appl. Microbiol. 1241 
Biotechnol. 33, 657Ȃ63. 1242 
(112) Fontaine, L., Meynial-Salles, I., Girbal, L., Yang, X., Croux, C., and Soucaille, P. (2002) 1243 
Molecular characterization and transcriptional analysis of adhE2, the gene encoding the 1244 
NADH-dependent aldehyde/alcohol dehydrogenase responsible for butanol production 1245 
in alcohologenic cultures of Clostridium acetobutylicum ATCC 824. J. Bacteriol. 184, 821Ȃ1246 
830. 1247 
(113) Ciampi, M. S. (2006) Rho-dependent terminators and transcription termination. 1248 
Microbiology 152, 2515Ȃ2528. 1249 
(114) Liu, C. C., Qi, L., Lucks, J. B., Segall-Shapiro, T. H., Wang, D., Mutalik, V. K., and Arkin, 1250 
A. P. (2012) An adaptor from translational to transcriptional control enables predictable 1251 
assembly of complex regulation. Nat. Methods 9, 1088Ȃ1094. 1252 
(115) Banerjee, S., Chalissery, J., Bandey, I., and Sen, R. (2006) Rho-dependent 1253 
transcription termination: more questions than answers. J. Microbiol. 44, 11Ȃ22. 1254 
(116) Gardner, P. P., Barquist, L., Bateman, A., Nawrocki, E. P., and Weinberg, Z. (2011) 1255 
RNIE: Genome-wide prediction of bacterial intrinsic terminators. Nucleic Acids Res. 39, 1256 
5845Ȃ5852. 1257 
(117) Gusarov, I., and Nudler, E. (1999) The mechanism of intrinsic transcription 1258 
termination. Mol. Cell 3, 495Ȃ504. 1259 
(118) Sugimoto, N., Nakano, S. ichi, Katoh, M., Matsumura, A., Nakamuta, H., Ohmichi, T., 1260 
Yoneyama, M., and Sasaki, M. (1995) Thermodynamic Parameters To Predict Stability of 1261 
RNA/DNA Hybrid Duplexes. Biochemistry 34, 11211Ȃ11216. 1262 
(119) Naville, M., and Gautheret, D. (2010) Premature terminator analysis sheds light on 1263 
a hidden world of bacterial transcriptional attenuation. Genome Biol. 11, R97. 1264 
(120) Ravagnani, A., Jennert, K. C. B., Steiner, E., Grünberg, R., Jefferies, J. R., Wilkinson, S. 1265 
R., Young, D. I., Tidswell, E. C., Brown, D. P., Youngman, P., Gareth Morris, J., and Young, 1266 
M. (2000) Spo0A directly controls the switch from acid to solvent production in solvent-1267 
forming clostridia. Mol. Microbiol. 37, 1172Ȃ1185. 1268 
(121) Wang, Y., Zhang, Z. T., Seo, S. O., Lynn, P., Lu, T., Jin, Y. S., and Blaschek, H. P. (2016) 1269 
Bacterial Genome Editing with CRISPR-Cas9: Deletion, Integration, Single Nucleotide 1270 ǡǲǳClostridium beijerinckii as an 1271 
Example. ACS Synth. Biol. 5, 721Ȃ732. 1272 
(122) Carrier, T. A., and Keasling, J. D. (1997) Controlling messenger RNA stability in 1273 
bacteria: Strategies for engineering gene expression. Biotechnol. Prog. 13, 699Ȃ708. 1274 
(123) Chen, Y.-J., Liu, P., Nielsen, A. A. K., Brophy, J. A. N., Clancy, K., Peterson, T., and 1275 
Voigt, C. A. (2013) Characterization of 582 natural and synthetic terminators and 1276 
quantification of their design constraints. Nat. Methods 10, 659Ȃ664. 1277 
(124) Lin, M. T., Wang, C. Y., Xie, H. J., Cheung, C. H. Y., Hsieh, C. H., Juan, H. F., Chen, B. 1278 
Sen, and Lin, C. (2016) Novel Utilization of Terminators in the Design of Biologically 1279 
Adjustable Synthetic Filters. ACS Synth. Biol. 5, 365Ȃ374. 1280 
(125) Abe, H., Abo, T., and Aiba, H. (1999) Regulation of intrinsic terminator by 1281 
translation in Escherichia coli: transcription termination at a distance downstream. 1282 
Genes Cells 4, 87Ȃ97. 1283 
(126) Li, R., Zhang, Q., Li, J., and Shi, H. (2015) Effects of cooperation between translating 1284 
ribosome and RNA polymerase on termination efficiency of the Rho-independent 1285 
terminator. Nucleic Acids Res. 44, 2554Ȃ2563. 1286 
(127) Lesnik, E. A., Sampath, R., Levene, H. B., Henderson, T. J., McNeil, J. A., and Ecker, D. 1287 
J. (2001) Prediction of rho-independent transcriptional terminators in Escherichia coli. 1288 
Nucleic Acids Res. 29, 3583Ȃ94. 1289 
(128) Kingsford, C. L., Ayanbule, K., and Salzberg, S. L. (2007) Rapid, accurate, 1290 
computational discovery of Rho-independent transcription terminators illuminates their 1291 
relationship to DNA uptake. Genome Biol. 8, R22. 1292 
(129) Mitra, A., Angamuthu, K., Jayashree, H. V., and Nagaraja, V. (2009) Occurrence, 1293 
divergence and evolution of intrinsic terminators across Eubacteria. Genomics 94, 110Ȃ1294 
116. 1295 
(130) Mitra, A., Kesarwani, A. K., Pal, D., and Nagaraja, V. (2011) WebGeSTer DB-A 1296 
transcription terminator database. Nucleic Acids Res. 39, D129-35. 1297 
(131) Wright, J. J., Kumar, A., and Hayward, R. S. (1992) Hypersymmetry in a 1298 
transcriptional terminator of Escherichia coli confers increased efficiency as well as 1299 
bidirectionality. EMBO J. 11, 1957Ȃ64. 1300 
(132) Yang, M. Te, Scott, H. B., and Gardner, J. F. (1995) Transcription termination at the 1301 
thr attenuator: Evidence that the adenine residues upstream of the stem and loop 1302 
structure are not required for termination. J. Biol. Chem. 270, 23330Ȃ23336. 1303 
(133) Paredes, C. J., Rigoutsos, I., and Papoutsakis, T. (2004) Transcriptional 1304 
organization of the Clostridium acetobutylicum genome. Nucleic Acids Res. 32, 1973Ȃ1305 
1981. 1306 
(134) Shultzaberger, R. K., Bucheimer, R. E., Rudd, K. E., and Schneider, T. D. (2001) 1307 
Anatomy of Escherichia coli ribosome binding sites. J. Mol. Biol. 313, 215Ȃ228. 1308 
(135) Yang, Y., Lang, N., Yang, G., Yang, S., Jiang, W., and Gu, Y. (2016) Improving the 1309 
performance of solventogenic clostridia by reinforcing the biotin synthetic pathway. 1310 
Metab. Eng. 35, 121Ȃ128. 1311 
(136) Yang, G., Jia, D., Jin, L., Jiang, Y., Wang, Y., Jiang, W., and Gu, Y. (2017) Rapid 1312 
Generation of Universal Synthetic Promoters for Controlled Gene Expression in Both 1313 
Gas-Fermenting and Saccharolytic Clostridium Species. ACS Synth. Biol. 6, 1672Ȃ1678. 1314 
(137) Chen, H., Bjerknes, M., Kumar, R., and Jay, E. (1994) Determination of the optimal 1315 
aligned spacing between the Shine - Dalgarno sequence and the translation initiation 1316 
codon of Escherichia coli mRNAs. Nucleic Acids Res. 22, 4953Ȃ4957. 1317 
(138) Hager, P. W., and Rabinowitz, J. C. (1985) Translational specificity in Bacillus 1318 
subtilis. Mol. Biol. bacilli 2, 1Ȃ32. 1319 
(139) Band, L., and Henner, D. J. (1984) Bacillus subtilis ǲǳ-1320 
Dalgarno region for gene expression. DNA 3, 17Ȃ21. 1321 
(140) Abolbaghaei, A., Silke, J. R., and Xia, X. (2017) How Changes in Anti-SD Sequences 1322 
Would Affect SD Sequences in Escherichia coli and Bacillus subtilis. G3 (Bethesda). 7, 1323 
1607Ȃ1615. 1324 
(141) Dunn, J. J., and Studier, F. W. (1981) Nucleotide sequence from the genetic left end 1325 
of bacteriophage T7 DNA to the beginning of gene 4. J. Mol. Biol. 148, 303Ȃ330. 1326 
(142) Ringquist, S., Shinedling, S., Barrick, D., Green, L., Binkley, J., Stormo, G. D., and 1327 
Gold, L. (1992) Translation initiation in Escherichia coliǣǦ1328 
binding site. Mol. Microbiol. 6, 1219Ȃ1229. 1329 
(143) Garnier, T., Canard, B., and Cole, S. T. (1991) Cloning, mapping, and molecular 1330 
characterization of the rRNA operons of Clostridium perfringens. J. Bacteriol. 173, 5431Ȃ1331 
5438. 1332 
(144) Ma, J., Campbell, A., and Karlin, S. (2002) Correlations between Shine-Dalgarno 1333 
sequences and gene features such as predicted expression levels and operon structures. 1334 
J. Bacteriol. 184, 5733Ȃ5745. 1335 
(145) He, J., Sakaguchi, K., and Suzuki, T. (2012) Determination of the ribosome-binding 1336 
sequence and spacer length between binding site and initiation codon for efficient 1337 
protein expression in Bifidobacterium longum 105-A. J. Biosci. Bioeng. 113, 442Ȃ444. 1338 
(146) Salis, H. M. (2011) The ribosome binding site calculator. Methods Enzymol. 498, 1339 
19Ȃ42. 1340 
(147) Salis, H. M., Mirsky, E. A., and Voigt, C. A. (2009) Automated design of synthetic 1341 
ribosome binding sites to control protein expression. Nat. Biotechnol. 27, 946Ȃ950. 1342 
(148) Reeve, B., Martinez-Klimova, E., De Jonghe, J., Leak, D. J., and Ellis, T. (2016) The 1343 
Geobacillus Plasmid Set: A Modular Toolkit for Thermophile Engineering. ACS Synth. Biol. 1344 
5, 1342Ȃ1347. 1345 
(149) Ikemura, T. (1985) Codon usage and tRNA content in unicellular and multicellular 1346 
organisms. Mol. Biol. Evol. 2, 13Ȃ34. 1347 
(150) Sharp, P. M., and Li, W. H. (1987) The codon adaptation index-a measure of 1348 
directional synonymous codon usage bias, and its potential applications. Nucleic Acids 1349 
Res. 15, 1281Ȃ1295. 1350 
(151) Baca, A. M., and Hol, W. G. J. (2000) Overcoming codon bias: A method for high-1351 
level overexpression of Plasmodium and other AT-rich parasite genes in Escherichia coli. 1352 
Int. J. Parasitol. 30, 113Ȃ118. 1353 
(152) Novy, R., Drott, D., Yaeger, K., and Mierendorf, R. (2001) Overcoming the codon 1354 
bias of E. coli for enhanced protein expression. Innovations 12, 4Ȃ6. 1355 
(153) Mondal, S. K., Kundu, S., Das, R., and Roy, S. (2016) Analysis of phylogeny and 1356 
codon usage bias and relationship of GC content, amino acid composition with 1357 
expression of the structural nif genes. J. Biomol. Struct. Dyn. 34, 1649Ȃ1666. 1358 
(154) Musto, H., Romero, H., and Zavala, A. (2003) Translational selection is operative 1359 
for synonymous codon usage in Clostridium perfringens and Clostridium acetobutylicum. 1360 
Microbiology 149, 855Ȃ863. 1361 
(155) Sastalla, I., Chim, K., Cheung, G. Y. C., Pomerantsev, A. P., and Leppla, S. H. (2009) 1362 
Codon-optimized fluorescent proteins designed for expression in low-GC gram-positive 1363 
bacteria. Appl. Environ. Microbiol. 75, 2099Ȃ2110. 1364 ȋ ? ? ?Ȍǡ	Ǥȋ ? ? ? ?ȌǲǳǤGene 87, 23Ȃ29. 1365 
(157) Kudla, G., Murray, A. W., Tollervey, D., and Plotkin, J. B. (2009) Coding-Sequence 1366 
Determinants of Gene Expression in Escherichia coli. Science (80-. ). 324, 255Ȃ258. 1367 
(158) Welch, M., Govindarajan, S., Ness, J. E., Villalobos, A., Gurney, A., Minshull, J., and 1368 
Gustafsson, C. (2009) Design parameters to control synthetic gene expression in 1369 
Escherichia coli. PLoS One 4, e7002. 1370 
(159) Xia, X. (2007) An improved implementation of codon adaptation index. Evol. 1371 
Bioinforma. 3, 53Ȃ58. 1372 
(160) Xia, X. (2015) A major controversy in codon-Anticodon adaptation resolved by a 1373 
new codon usage index. Genetics 199, 573Ȃ579. 1374 
(161) Lanza, A. M., Curran, K. A., Rey, L. G., and Alper, H. S. (2014) A condition-specific 1375 
codon optimization approach for improved heterologous gene expression in 1376 
Saccharomyces cerevisiae. BMC Syst. Biol. 8, 33. 1377 ȋ ? ? ?ȌǡǤǡǡǤǡ
ǡǤǡǡǤȋ ? ? ? ?Ȍǯ1378 
googol: optimizing genes for protein expression. J. R. Soc. Interface 6, S467ȂS476. 1379 
(163) Plotkin, J. B., and Kudla, G. (2011) Synonymous but not the same: the causes and 1380 
consequences of codon bias. Nat. Rev. Genet. 12, 32Ȃ42. 1381 
(164) Carrier, T. A., and Keasling, ǤǤȋ ? ? ? ?Ȍ ?ǯ1382 
structures to manipulate mRNA stability in Escherichia coli. Biotechnol. Prog. 15, 58Ȃ64. 1383 
(165) Condon, C., and Putzer, H. (2002) The phylogenetic distribution of bacterial 1384 
ribonucleases. Nucleic Acids Res. 30, 5339Ȃ5346. 1385 
(166) Durand, S., Tomasini, A., Braun, F., Condon, C., and Romby, P. (2015) sRNA and 1386 
mRNA turnover in Gram-positive bacteria. FEMS Microbiol. Rev. 39, 316Ȃ330. 1387 
(167) Lehnik-Habrink, M., Newman, J., Rothe, F. M., Solovyova, A. S., Rodrigues, C., 1388 
Herzberg, C., Commichau, F. M., Lewis, R. J., and Stülke, J. (2011) RNase Y in Bacillus 1389 
subtilis: A natively disordered protein that is the functional equivalent of RNase E from 1390 
Escherichia coli. J. Bacteriol. 193, 5431Ȃ5441. 1391 
(168) Lee, J., Jang, Y. S., Papoutsakis, E. T., and Lee, S. Y. (2016) Stable and enhanced gene 1392 
expression in Clostridium acetobutylicum using synthetic untranslated regions with a 1393 
stem-loop. J. Biotechnol. 230, 40Ȃ43. 1394 
(169) Desai, R. P., and Papoutsakis, E. T. (1999) Antisense RNA strategies for metabolic 1395 
engineering of Clostridium acetobutylicum. Appl. Environ. Microbiol. 65, 936Ȃ945. 1396 
(170) Song, J.-W., Woo, J.-M., Jung, G. Y., Bornscheuer, U. T., and Park, J.-Ǥȋ ? ? ? ?Ȍ ?B?-UTR 1397 
engineering to improve soluble expression and fine-tuning of activity of cascade 1398 
enzymes in Escherichia coli. Sci. Rep. 6, 29406. 1399 
(171) Tummala, S. B., Junne, S. G., and Papoutsakis, E. T. (2003) Antisense RNA 1400 
downregulation of coenzyme A transferase combined with alcohol-aldehyde 1401 
dehydrogenase overexpression leads to predominantly alcohologenic Clostridium 1402 
acetobutylicum fermentations. J. Bacteriol. 185, 3644Ȃ3653. 1403 
(172) Pyne, M., Moo-Young, M., Chung, D., and Chou, C. (2015) Antisense-RNA-Mediated 1404 
Gene Downregulation in Clostridium pasteurianum. Fermentation 1, 113Ȃ126. 1405 
(173) Storz, G., Altuvia, S., and Wassarman, K. M. (2005) AN ABUNDANCE OF RNA 1406 
REGULATORS. Annu. Rev. Biochem. 74, 199Ȃ217. 1407 
(174) Mutalik, V. K., Qi, L., Guimaraes, J. C., Lucks, J. B., and Arkin, A. P. (2012) Rationally 1408 
designed families of orthogonal RNA regulators of translation. Nat. Chem. Biol. 8, 447Ȃ1409 
454. 1410 
(175) Isaacs, F. J., Dwyer, D. J., Ding, C., Pervouchine, D. D., Cantor, C. R., and Collins, J. J. 1411 
(2004) Engineered riboregulators enable post-transcriptional control of gene 1412 
expression. Nat. Biotechnol. 22, 841Ȃ847. 1413 
(176) Green, A. A., Silver, P. A., Collins, J. J., and Yin, P. (2014) Toehold switches: De-novo-1414 
designed regulators of gene expression. Cell 159, 925Ȃ939. 1415 
(177) Garst, A. D., Edwards, A. L., and Batey, R. T. (2011) Riboswitches: Structures and 1416 
mechanisms. Cold Spring Harb. Perspect. Biol. 3, 1Ȃ13. 1417 
(178) Mellin, J. R., and Cossart, P. (2015) Unexpected versatility in bacterial 1418 
riboswitches. Trends Genet. 31, 150Ȃ156. 1419 
(179) Wittmann, A., and Suess, B. (2012) Engineered riboswitches: Expanding 1420 ǯǤFEBS Lett. 586, 2076Ȃ2083. 1421 
(180) Saad, N. Y., Schiel, B., Brayé, M., Heap, J. T., Minton, N. P., Dürre, P., and Becker, H. D. 1422 
(2012) Riboswitch (T-box)-mediated control of tRNA-dependent amidation in 1423 
Clostridium acetobutylicum rationalizes gene and pathway redundancy for asparagine 1424 
and asparaginyl-tRNAAsn synthesis. J. Biol. Chem. 287, 20382Ȃ20394. 1425 
(181) André, G., Even, S., Putzer, H., Burguière, P., Croux, C., Danchin, A., Martin-1426 
Verstraete, I., and Soutourina, O. (2008) S-box and T-box riboswitches and antisense 1427 
RNA control a sulfur metabolic operon of Clostridium acetobutylicum. Nucleic Acids Res. 1428 
36, 5955Ȃ5969. 1429 
(182) Kim, P. B., Nelson, J. W., and Breaker, R. R. (2015) An ancient riboswitch class in 1430 
bacteria regulates purine biosynthesis and one-carbon metabolism. Mol. Cell 57, 317Ȃ1431 
328. 1432 
(183) Projan, S. J., Monod, M., Narayanan, C. S., and Dubnau, D. (1987) Replication 1433 
properties of pIM13, a naturally occurring plasmid found in Bacillus subtilis, and of its 1434 
close relative pE5, a plasmid native to Staphylococcus aureus. J. Bacteriol. 169, 5131Ȃ1435 
5139. 1436 
(184) Garnier, T., and Cole, S. T. (1988) Identification and Molecular Genetic Analysis of 1437 
Replication Functions of the Bacteriocinogenic Plasmid plP404 from Clostridium 1438 
perfringens. Plasmid 19, 151Ȃ160. 1439 ȋ ? ? ?ȌǡǤǡǯǡǤǤǤǡǡǤǡǡǤǡǡǤǡ-Brown, M., 1440 
Ostrowski, A., and Minton, N. P. (2002) Conjugative transfer of clostridial shuttle vectors 1441 
from Escherichia coli to Clostridium difficile through circumvention of the restriction 1442 
barrier. Mol. Microbiol. 46, 439Ȃ452. 1443 
(186) Lee, S. H., Kwon, M. A., Choi, S., Kim, S., Kim, J., Shin, Y. A., and Kim, K. H. (2015) A 1444 
new shuttle plasmid that stably replicates in Clostridium acetobutylicum. J. Microbiol. 1445 
Biotechnol. 25, 1702Ȃ1708. 1446 
(187) Li, Y., Blaschek, H. P., and Tan, D. (2002) Molecular characterization and utilization 1447 
of the CAK1 filamentous viruslike particle derived from Clostridium beijerinckii. J. Ind. 1448 
Microbiol. Biotechnol. 28, 118Ȃ26. 1449 
(188) Nakayama, S., Irie, R., Kosaka, T., Matsuura, K., Yoshino, S., and Furukawa, K. 1450 
(2007) New host-vector system in solvent-producing Clostridium 1451 
saccharoperbutylacetonicum strain N1-4. J. Gen. Appl. Microbiol. 53, 53Ȃ6. 1452 
(189) Maguin, E., Duwat, P., Hege, T., Ehrlich, D., and Gruss, A. (1992) New 1453 
thermosensitive plasmid for gram-positive bacteria. J. Bacteriol. 174, 5633Ȃ5638. 1454 
(190) Heap, J. T., Ehsaan, M., Cooksley, C. M., Ng, Y. K., Cartman, S. T., Winzer, K., and 1455 
Minton, N. P. (2012) Integration of DNA into bacterial chromosomes from plasmids 1456 
without a counter-selection marker. Nucleic Acids Res. 40, e59. 1457 
(191) Gu, P., Yang, F., Su, T., Wang, Q., Liang, Q., and Qi, Q. (2015) A rapid and reliable 1458 
strategy for chromosomal integration of gene(s) with multiple copies. Sci. Rep. 5, 9684. 1459 
(192) Kuhlman, T. E., and Cox, E. C. (2010) Site-specific chromosomal integration of 1460 
large synthetic constructs. Nucleic Acids Res. 38, e92. 1461 
(193) Bryant, J. A., Sellars, L. E., Busby, S. J. W., and Lee, D. J. (2014) Chromosome 1462 
position effects on gene expression in Escherichia coli K-12. Nucleic Acids Res. 42, 11383Ȃ1463 
11392. 1464 
(194) Berger, M., Gerganova, V., Berger, P., Rapiteanu, R., and Lisicovas, V. (2016) Genes 1465 W?ǣ- Associated Protein HU Insulates Transcription Units in 1466 
Escherichia coli. Nat. Publ. Gr. 6, 1Ȃ12. 1467 
(195) Sauer, C., Syvertsson, S., Bohorquez, L. C., Cruz, R., Harwood, C. R., Van Rij, T., and 1468 
Hamoen, L. W. (2016) Effect of Genome Position on Heterologous Gene Expression in 1469 
Bacillus subtilis: An Unbiased Analysis. ACS Synth. Biol. 5, 942Ȃ947. 1470 
(196) Anuchin, A. M., Goncharenko, A. V, Demidenok, O. I., and Kaprelyants, A. S. (2011) 1471 
Histone-like proteins of bacteria (review). Appl. Biochem. Microbiol. 47, 580Ȃ585. 1472 
(197) Sharan, S. K., Thomason, L. C., Kuznetsov, S. G., and Court, D. L. (2009) 1473 
Recombineering: a homologous recombination-based method of genetic engineering. 1474 
Nat. Protoc. 4, 206Ȃ223. 1475 
(198) Li, Y., Lin, Z., Huang, C., Zhang, Y., Wang, Z., Tang, Y. jie, Chen, T., and Zhao, X. 1476 
(2015) Metabolic engineering of Escherichia coli using CRISPR-Cas9 meditated genome 1477 
editing. Metab. Eng. 31, 13Ȃ21. 1478 
(199) Jiang, Y., Chen, B., Duan, C., Sun, B., Yang, J., and Yang, S. (2015) Multigene editing 1479 
in the Escherichia coli genome via the CRISPR-Cas9 system. Appl. Environ. Microbiol. 81, 1480 
2506Ȃ2514. 1481 
(200) Croux, C., Nguyen, N.-P.-T., Lee, J., Raynaud, C., Saint-Prix, F., Gonzalez-Pajuelo, M., 1482 
Meynial-Salles, I., and Soucaille, P. (2016) Construction of a restriction-less, marker-less 1483 
mutant useful for functional genomic and metabolic engineering of the biofuel producer 1484 
Clostridium acetobutylicum. Biotechnol. Biofuels 9, 23. 1485 
(201) Yoo, M., Croux, C., Meynial-Salles, I., and Soucaille, P. (2016) Elucidation of the 1486 
roles of adhE1 and adhE2 in the primary metabolism of Clostridium acetobutylicum by 1487 
combining in-frame gene deletion and a quantitative system-scale approach. Biotechnol. 1488 
Biofuels 9, 92. 1489 
(202) Zhang, N., Shao, L., Jiang, Y., Gu, Y., Li, Q., Liu, J., Jiang, W., and Yang, S. (2015) I-SceI-1490 
mediated scarless gene modification via allelic exchange in Clostridium. J. Microbiol. 1491 
Methods 108, 49Ȃ60. 1492 
(203) Dong, H., Tao, W., Gong, F., Li, Y., and Zhang, Y. (2014) A functional recT gene for 1493 
recombineering of Clostridium. J. Biotechnol. 173, 65Ȃ67. 1494 
(204) Wang, Y., Zhang, Z. T., Seo, S. O., Choi, K., Lu, T., Jin, Y. S., and Blaschek, H. P. (2015) 1495 
Markerless chromosomal gene deletion in Clostridium beijerinckii using CRISPR/Cas9 1496 
system. J. Biotechnol. 200, 1Ȃ5. 1497 
(205) Pyne, M. E., Bruder, M. R., Moo-Young, M., Chung, D. A., and Chou, C. P. (2016) 1498 
Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient 1499 
markerless genome editing in Clostridium. Sci. Rep. 6, 25666. 1500 
(206) Wang, S., Dong, S., Wang, P., Tao, Y., and Wang, Y. (2017) Genome editing in 1501 
Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 system. Appl. 1502 
Environ. Microbiol. 83. 1503 
(207) Kosuri, S., Goodman, D. B., Cambray, G., Mutalik, V. K., Gao, Y., Arkin, A. P., Endy, D., 1504 
and Church, G. M. (2013) Composability of regulatory sequences controlling 1505 
transcription and translation in Escherichia coli. Proc. Natl. Acad. Sci. 110, 14024Ȃ14029. 1506 
(208) Lou, C., Stanton, B., Chen, Y.-J., Munsky, B., and Voigt, C. A. (2012) Ribozyme-based 1507 
insulator parts buffer synthetic circuits from genetic context. Nat. Biotechnol. 30, 1137Ȃ1508 
1142. 1509 
(209) Davis, J. H., Rubin, A. J., and Sauer, R. T. (2011) Design, construction and 1510 
characterization of a set of insulated bacterial promoters. Nucleic Acids Res. 39, 1131Ȃ1511 
1141. 1512 
(210) Qi, L., Haurwitz, R. E., Shao, W., Doudna, J. A., and Arkin, A. P. (2012) RNA 1513 
processing enables predictable programming of gene expression. Nat. Biotechnol. 30, 1514 
1002Ȃ1006. 1515 
(211) Nielsen, A. A. K., Segall-Shapiro, T. H., and Voigt, C. A. (2013) Advances in genetic 1516 
circuit design: Novel biochemistries, deep part mining, and precision gene expression. 1517 
Curr. Opin. Chem. Biol. 17, 878Ȃ892. 1518 
(212) Mutalik, V. K., Guimaraes, J. C., Cambray, G., Lam, C., Christoffersen, M. J., Mai, Q.-A., 1519 
Tran, A. B., Paull, M., Keasling, J. D., Arkin, A. P., and Endy, D. (2013) Precise and reliable 1520 
gene expression via standard transcription and translation initiation elements. Nat. 1521 
Methods 10, 354Ȃ360. 1522 
(213) Bardhan, S. K., Gupta, S., Gorman, M. E., and Haider, M. A. (2015) Biorenewable 1523 
chemicals: Feedstocks, technologies and the conflict with food production. Renew. 1524 
Sustain. Energy Rev. 51, 506Ȃ520. 1525 
(214) Papoutsakis, E. T. (2008) Engineering solventogenic clostridia. Curr. Opin. 1526 
Biotechnol. 19, 420Ȃ9. 1527 
(215) Lorenz, R., Bernhart, S. S. H., Höner zu Siederdissen, C., Tafer, H., Flamm, C., 1528 
Stadler, P. F. P., and Hofacker, I. I. L. (2011) ViennaRNA Package 2.0. Algorithms Mol. Biol. 1529 
6, 26. 1530 
(216) Gruber, A. R., Lorenz, R., Bernhart, S. H., Neuböck, R., and Hofacker, I. L. (2008) The 1531 
Vienna RNA websuite. Nucleic Acids Res. 36, W70-4. 1532 
(217) Darty, K., Denise, A., and Ponty, Y. (2009) VARNA: Interactive drawing and editing 1533 
of the RNA secondary structure. Bioinformatics 25, 1974Ȃ1975. 1534 
(218) Wilson, K. S., and Hippel, P. H. Von. (1995) Transcription termination at intrinsic 1535 
terminators: The role of the RNA hairpin (Escherichia coli/RNA polymerase/rho-1536 
independent termination). Biochemistry 92, 8793Ȃ8797. 1537 
 1538 
